| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transcription factor binding | HDAC9 CAND1 HDAC4 SREBF1 PRAMEF2 TRIM11 CIITA NFATC3 NFE2L2 UHRF2 MED13 ZBTB8A PRAMEF12 BBS5 PPID ATXN3L ELK1 PRKDC SPEN PADI2 PRAME | 9.04e-06 | 753 | 188 | 21 | GO:0008134 |
| GeneOntologyMolecularFunction | RNA polymerase II-specific DNA-binding transcription factor binding | HDAC9 HDAC4 PRAMEF2 NFE2L2 UHRF2 MED13 ZBTB8A PRAMEF12 BBS5 PPID ELK1 PRKDC SPEN PADI2 PRAME | 1.02e-05 | 417 | 188 | 15 | GO:0061629 |
| GeneOntologyMolecularFunction | DNA-binding transcription factor binding | HDAC9 HDAC4 PRAMEF2 CIITA NFE2L2 UHRF2 MED13 ZBTB8A PRAMEF12 BBS5 PPID ELK1 PRKDC SPEN PADI2 PRAME | 1.31e-04 | 582 | 188 | 16 | GO:0140297 |
| GeneOntologyMolecularFunction | guanyl-nucleotide exchange factor activity | TRIO OBSCN ARHGEF17 DENND5A HERC2 DNMBP DENND5B VPS9D1 DENND2C | 3.53e-04 | 231 | 188 | 9 | GO:0005085 |
| GeneOntologyMolecularFunction | SUMO transferase activity | 3.54e-04 | 36 | 188 | 4 | GO:0019789 | |
| GeneOntologyMolecularFunction | K63-linked deubiquitinase activity | 4.20e-04 | 16 | 188 | 3 | GO:0061578 | |
| GeneOntologyMolecularFunction | microfilament motor activity | 4.37e-04 | 38 | 188 | 4 | GO:0000146 | |
| GeneOntologyMolecularFunction | aminoacyltransferase activity | HDAC4 FBXL3 TRIM11 HERC2 MED7 UHRF2 RGPD2 RANBP2 ITCH TGM2 NEURL1 ASB2 LONRF2 FBXW7 | 5.35e-04 | 532 | 188 | 14 | GO:0016755 |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 8.86e-04 | 118 | 188 | 6 | GO:0003774 | |
| GeneOntologyMolecularFunction | K48-linked deubiquitinase activity | 9.64e-04 | 21 | 188 | 3 | GO:1990380 | |
| GeneOntologyMolecularFunction | molecular adaptor activity | HDAC9 MYD88 HDAC4 ATG2A PRAMEF2 DLGAP3 TRIM11 CIITA ANAPC1 NFE2L2 HRAS AP1G2 MED7 MED13 KRAS SUPT20H STON1 EID2 PRAMEF12 MYH14 ELK1 SCRIB SPEN PRAME FBXW7 | 9.69e-04 | 1356 | 188 | 25 | GO:0060090 |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | TRIO OBSCN ARHGEF17 TBC1D24 DENND5A HERC2 DNMBP DENND5B RGPD2 RANBP2 VPS9D1 DENND2C ARHGAP45 | 1.07e-03 | 507 | 188 | 13 | GO:0060589 |
| GeneOntologyMolecularFunction | GTPase regulator activity | TRIO OBSCN ARHGEF17 TBC1D24 DENND5A HERC2 DNMBP DENND5B RGPD2 RANBP2 VPS9D1 DENND2C ARHGAP45 | 1.07e-03 | 507 | 188 | 13 | GO:0030695 |
| GeneOntologyMolecularFunction | phosphatidylinositol-3-phosphate binding | 1.07e-03 | 48 | 188 | 4 | GO:0032266 | |
| GeneOntologyMolecularFunction | ubiquitin-like protein transferase activity | HDAC4 FBXL3 TRIM11 HERC2 MED7 UHRF2 RGPD2 RANBP2 ITCH NEURL1 ASB2 LONRF2 FBXW7 | 1.17e-03 | 512 | 188 | 13 | GO:0019787 |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | HDAC9 MYD88 HDAC4 ATG2A PRAMEF2 TRIM11 CIITA NFE2L2 HRAS AP1G2 MED7 MED13 KRAS SUPT20H STON1 EID2 PRAMEF12 ELK1 SCRIB SPEN PRAME FBXW7 | 1.39e-03 | 1160 | 188 | 22 | GO:0030674 |
| GeneOntologyMolecularFunction | GTP binding | 1.40e-03 | 397 | 188 | 11 | GO:0005525 | |
| GeneOntologyMolecularFunction | ubiquitin-like protein ligase activity | TRIM11 HERC2 MED7 UHRF2 RGPD2 RANBP2 ITCH NEURL1 ASB2 LONRF2 FBXW7 | 1.43e-03 | 398 | 188 | 11 | GO:0061659 |
| GeneOntologyMolecularFunction | histone deacetylase activity | 1.44e-03 | 24 | 188 | 3 | GO:0004407 | |
| GeneOntologyMolecularFunction | protein lysine deacetylase activity | 1.62e-03 | 25 | 188 | 3 | GO:0033558 | |
| GeneOntologyBiologicalProcess | skeletal muscle tissue development | HDAC9 HDAC4 NFATC3 DMD KRAS NRAS ABCC9 MYH14 NEURL1 SRPK3 MYOM2 ASB2 | 8.08e-07 | 223 | 184 | 12 | GO:0007519 |
| GeneOntologyBiologicalProcess | skeletal muscle organ development | HDAC9 HDAC4 NFATC3 DMD KRAS NRAS ABCC9 MYH14 NEURL1 SRPK3 MYOM2 ASB2 | 1.75e-06 | 240 | 184 | 12 | GO:0060538 |
| GeneOntologyBiologicalProcess | muscle organ development | HDAC9 EPOR HDAC4 NFATC3 DMD UTRN KRAS NRAS EID2 ABCC9 MYH14 NEURL1 SRPK3 MYOM2 ASB2 | 9.11e-06 | 436 | 184 | 15 | GO:0007517 |
| GeneOntologyCellularComponent | myosin filament | 6.91e-05 | 25 | 188 | 4 | GO:0032982 | |
| GeneOntologyCellularComponent | ubiquitin ligase complex | CAND1 PRAMEF2 FBXL3 ANAPC1 MED7 ITCH PRAMEF12 FBXL16 ASB2 FBXL20 PRAME FBXW7 | 8.66e-05 | 352 | 188 | 12 | GO:0000151 |
| GeneOntologyCellularComponent | cullin-RING ubiquitin ligase complex | CAND1 PRAMEF2 FBXL3 ANAPC1 PRAMEF12 FBXL16 FBXL20 PRAME FBXW7 | 1.33e-04 | 212 | 188 | 9 | GO:0031461 |
| GeneOntologyCellularComponent | transferase complex | HDAC9 CAND1 PRAMEF2 FBXL3 PIK3C3 ANAPC1 MED7 MED13 RGPD2 RANBP2 ITCH SUPT20H PRAMEF12 REV3L FBXL16 PRKDC ASB2 FBXL20 PARD3 PRAME FBXW7 | 1.63e-04 | 963 | 188 | 21 | GO:1990234 |
| GeneOntologyCellularComponent | myosin complex | 1.88e-04 | 59 | 188 | 5 | GO:0016459 | |
| HumanPheno | Linear nevus sebaceous | 2.49e-06 | 3 | 70 | 3 | HP:0010817 | |
| HumanPheno | Nevus sebaceous | 2.44e-05 | 5 | 70 | 3 | HP:0010815 | |
| HumanPheno | Recurrent respiratory infections | MCIDAS INPPL1 SREBF1 NHLRC2 DNAL1 TBC1D24 BLM CIITA NFE2L2 PKHD1 LRRC56 HERC2 VPS51 KRAS DIP2B ITCH NRAS ROR2 ALOXE3 PRKDC HYDIN FBXW7 | 4.08e-05 | 660 | 70 | 22 | HP:0002205 |
| Domain | - | LRWD1 NAIP DNAL1 PRAMEF2 ERBIN FBXL3 CIITA ATRAID LRRC56 PRAMEF12 SHOC2 FBXL16 SCRIB FBXL20 SNRPA1 PRAME LRRD1 | 3.04e-08 | 321 | 189 | 17 | 3.80.10.10 |
| Domain | L_dom-like | LRWD1 NAIP DNAL1 PRAMEF2 ERBIN FBXL3 CIITA ATRAID LRRC56 PRAMEF12 SHOC2 FBXL16 SCRIB FBXL20 SNRPA1 PRAME LRRD1 | 4.17e-08 | 328 | 189 | 17 | IPR032675 |
| Domain | LRR_1 | LRWD1 DNAL1 ERBIN CIITA LRRC56 SHOC2 SCRIB FBXL20 SNRPA1 PRAME LRRD1 | 1.48e-05 | 219 | 189 | 11 | PF00560 |
| Domain | Leu-rich_rpt | LRWD1 DNAL1 ERBIN CIITA LRRC56 SHOC2 FBXL16 SCRIB FBXL20 SNRPA1 PRAME LRRD1 | 2.13e-05 | 271 | 189 | 12 | IPR001611 |
| Domain | PUA-like_domain | 3.50e-05 | 19 | 189 | 4 | IPR015947 | |
| Domain | Myosin_head_motor_dom | 3.85e-05 | 38 | 189 | 5 | IPR001609 | |
| Domain | MYOSIN_MOTOR | 3.85e-05 | 38 | 189 | 5 | PS51456 | |
| Domain | Myosin_head | 3.85e-05 | 38 | 189 | 5 | PF00063 | |
| Domain | MYSc | 3.85e-05 | 38 | 189 | 5 | SM00242 | |
| Domain | Cell_morpho_N | 1.02e-04 | 2 | 189 | 2 | IPR025614 | |
| Domain | CXorf40 | 1.02e-04 | 2 | 189 | 2 | IPR033615 | |
| Domain | Dystrophin | 1.02e-04 | 2 | 189 | 2 | IPR016344 | |
| Domain | Cell_Morphogen_C | 1.02e-04 | 2 | 189 | 2 | IPR025481 | |
| Domain | MOR2-PAG1_mid | 1.02e-04 | 2 | 189 | 2 | IPR029473 | |
| Domain | MOR2-PAG1_mid | 1.02e-04 | 2 | 189 | 2 | PF14228 | |
| Domain | MOR2-PAG1_C | 1.02e-04 | 2 | 189 | 2 | PF14225 | |
| Domain | MOR2-PAG1_N | 1.02e-04 | 2 | 189 | 2 | PF14222 | |
| Domain | DUF719 | 1.02e-04 | 2 | 189 | 2 | IPR007998 | |
| Domain | DUF719 | 1.02e-04 | 2 | 189 | 2 | PF05334 | |
| Domain | P-loop_NTPase | NAIP MYO5C BLM MDN1 CIITA MYO3B ARL13B HRAS ERAS KIF5A KRAS GNL3L NRAS TOR2A MYH7B ABCC9 MYH14 DHX32 HYDIN MYO16 MX1 | 1.43e-04 | 848 | 189 | 21 | IPR027417 |
| Domain | IQ | 1.72e-04 | 81 | 189 | 6 | SM00015 | |
| Domain | LRR | 2.14e-04 | 201 | 189 | 9 | PS51450 | |
| Domain | ASCH_domain | 3.04e-04 | 3 | 189 | 2 | IPR007374 | |
| Domain | HDAC4_Gln | 3.04e-04 | 3 | 189 | 2 | PF12203 | |
| Domain | ASCH | 3.04e-04 | 3 | 189 | 2 | SM01022 | |
| Domain | Hist_deacetylase_Gln_rich_N | 3.04e-04 | 3 | 189 | 2 | IPR024643 | |
| Domain | IQ_motif_EF-hand-BS | 3.05e-04 | 90 | 189 | 6 | IPR000048 | |
| Domain | uDENN | 3.42e-04 | 14 | 189 | 3 | SM00800 | |
| Domain | IQ | 3.65e-04 | 93 | 189 | 6 | PS50096 | |
| Domain | RAS | 4.16e-04 | 35 | 189 | 4 | PS51421 | |
| Domain | uDENN | 4.24e-04 | 15 | 189 | 3 | PF03456 | |
| Domain | Myosin_N | 4.24e-04 | 15 | 189 | 3 | PF02736 | |
| Domain | Myosin_N | 4.24e-04 | 15 | 189 | 3 | IPR004009 | |
| Domain | Small_GTPase_Ras | 5.17e-04 | 37 | 189 | 4 | IPR020849 | |
| Domain | DENN | 5.18e-04 | 16 | 189 | 3 | SM00799 | |
| Domain | DENN | 5.18e-04 | 16 | 189 | 3 | PF02141 | |
| Domain | dDENN | 5.18e-04 | 16 | 189 | 3 | PF03455 | |
| Domain | UDENN | 5.18e-04 | 16 | 189 | 3 | PS50946 | |
| Domain | DDENN | 5.18e-04 | 16 | 189 | 3 | PS50947 | |
| Domain | dDENN | 5.18e-04 | 16 | 189 | 3 | SM00801 | |
| Domain | dDENN_dom | 5.18e-04 | 16 | 189 | 3 | IPR005112 | |
| Domain | uDENN_dom | 5.18e-04 | 16 | 189 | 3 | IPR005113 | |
| Domain | DENN | 5.18e-04 | 16 | 189 | 3 | PS50211 | |
| Domain | DENN_dom | 5.18e-04 | 16 | 189 | 3 | IPR001194 | |
| Domain | Histone_deAcase_II_euk | 6.03e-04 | 4 | 189 | 2 | IPR017320 | |
| Domain | ZF_ZZ_2 | 7.44e-04 | 18 | 189 | 3 | PS50135 | |
| Domain | ZF_ZZ_1 | 7.44e-04 | 18 | 189 | 3 | PS01357 | |
| Domain | ZZ | 7.44e-04 | 18 | 189 | 3 | PF00569 | |
| Domain | Myosin-like_IQ_dom | 8.77e-04 | 19 | 189 | 3 | IPR027401 | |
| Domain | - | 8.77e-04 | 19 | 189 | 3 | 4.10.270.10 | |
| Domain | Znf_ZZ | 8.77e-04 | 19 | 189 | 3 | IPR000433 | |
| Domain | PRAME_family | 8.77e-04 | 19 | 189 | 3 | IPR026271 | |
| Domain | ZnF_ZZ | 8.77e-04 | 19 | 189 | 3 | SM00291 | |
| Domain | - | 1.19e-03 | 21 | 189 | 3 | 2.60.60.20 | |
| Domain | PLAT | 1.19e-03 | 21 | 189 | 3 | PF01477 | |
| Domain | PLAT/LH2_dom | 1.19e-03 | 21 | 189 | 3 | IPR001024 | |
| Domain | PLAT | 1.19e-03 | 21 | 189 | 3 | PS50095 | |
| Domain | Pectin_lyas_fold | 1.49e-03 | 6 | 189 | 2 | IPR012334 | |
| Domain | CLIC | 1.49e-03 | 6 | 189 | 2 | IPR002946 | |
| Domain | PbH1 | 1.49e-03 | 6 | 189 | 2 | SM00710 | |
| Domain | - | 1.49e-03 | 6 | 189 | 2 | 2.160.20.10 | |
| Domain | EF-hand_dom_typ1 | 1.49e-03 | 6 | 189 | 2 | IPR015153 | |
| Domain | EF-hand_dom_typ2 | 1.49e-03 | 6 | 189 | 2 | IPR015154 | |
| Domain | EF-hand_2 | 1.49e-03 | 6 | 189 | 2 | PF09068 | |
| Domain | EF-hand_3 | 1.49e-03 | 6 | 189 | 2 | PF09069 | |
| Domain | PbH1 | 1.49e-03 | 6 | 189 | 2 | IPR006626 | |
| Domain | Spectrin | 1.56e-03 | 23 | 189 | 3 | PF00435 | |
| Domain | Pectin_lyase_fold/virulence | 2.74e-03 | 8 | 189 | 2 | IPR011050 | |
| Domain | hEGF | 2.77e-03 | 28 | 189 | 3 | PF12661 | |
| Pathway | REACTOME_CONSTITUTIVE_SIGNALING_BY_OVEREXPRESSED_ERBB2 | 2.45e-06 | 11 | 134 | 4 | M29814 | |
| Pathway | REACTOME_ERYTHROPOIETIN_ACTIVATES_RAS | 7.26e-06 | 14 | 134 | 4 | M27908 | |
| Pathway | PID_TCR_RAS_PATHWAY | 7.26e-06 | 14 | 134 | 4 | M134 | |
| Pathway | REACTOME_ACTIVATION_OF_RAS_IN_B_CELLS | 8.28e-06 | 5 | 134 | 3 | M26921 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HBV_HBX_TO_RAS_ERK_SIGNALING_PATHWAY | 9.82e-06 | 15 | 134 | 4 | M47593 | |
| Pathway | REACTOME_SIGNALING_BY_ERBB2_ECD_MUTANTS | 1.30e-05 | 16 | 134 | 4 | M29847 | |
| Pathway | REACTOME_ESTROGEN_STIMULATED_SIGNALING_THROUGH_PRKCZ | 1.64e-05 | 6 | 134 | 3 | M27951 | |
| Pathway | KEGG_MEDICUS_VARIANT_LOSS_OF_RASSF1_TO_RAS_RASSF1_SIGNALING_PATHWAY | 1.64e-05 | 6 | 134 | 3 | M47433 | |
| Pathway | KEGG_MEDICUS_REFERENCE_REGULATION_OF_GF_RTK_RAS_ERK_SIGNALING_RAS_UBIQUITINATION_BY_CUL3_COMPLEX | 1.64e-05 | 6 | 134 | 3 | M47931 | |
| Pathway | KEGG_MEDICUS_REFERENCE_REGULATION_OF_GF_RTK_RAS_ERK_SIGNALING_SPRED_AND_NF1 | 1.64e-05 | 6 | 134 | 3 | M47932 | |
| Pathway | REACTOME_RAS_SIGNALING_DOWNSTREAM_OF_NF1_LOSS_OF_FUNCTION_VARIANTS | 2.86e-05 | 7 | 134 | 3 | M29717 | |
| Pathway | REACTOME_SOS_MEDIATED_SIGNALLING | 2.86e-05 | 7 | 134 | 3 | M19489 | |
| Pathway | WP_SEROTONIN_RECEPTOR_2_AND_ELKSRFGATA4_SIGNALING | 3.36e-05 | 20 | 134 | 4 | M39485 | |
| Pathway | REACTOME_ACTIVATED_NTRK3_SIGNALS_THROUGH_RAS | 4.54e-05 | 8 | 134 | 3 | M27919 | |
| Pathway | KEGG_MEDICUS_REFERENCE_REGULATION_OF_GF_RTK_RAS_ERK_SIGNALING_RASGAP | 4.54e-05 | 8 | 134 | 3 | M47935 | |
| Pathway | REACTOME_EGFR_TRANSACTIVATION_BY_GASTRIN | 6.77e-05 | 9 | 134 | 3 | M27156 | |
| Pathway | REACTOME_SHC_RELATED_EVENTS_TRIGGERED_BY_IGF1R | 6.77e-05 | 9 | 134 | 3 | M27173 | |
| Pathway | REACTOME_ACTIVATED_NTRK2_SIGNALS_THROUGH_RAS | 6.77e-05 | 9 | 134 | 3 | M27904 | |
| Pathway | REACTOME_SIGNALING_BY_ERYTHROPOIETIN | 8.46e-05 | 25 | 134 | 4 | M27865 | |
| Pathway | REACTOME_SIGNALING_BY_ERBB2_IN_CANCER | 9.92e-05 | 26 | 134 | 4 | M29535 | |
| Pathway | BIOCARTA_RANBP2_PATHWAY | 1.31e-04 | 11 | 134 | 3 | M22027 | |
| Pathway | REACTOME_SIGNALING_BY_FGFR4_IN_DISEASE | 1.31e-04 | 11 | 134 | 3 | M27535 | |
| Pathway | KEGG_MEDICUS_VARIANT_RET_FUSION_KINASE_TO_RAS_ERK_SIGNALING_PATHWAY | 1.31e-04 | 11 | 134 | 3 | M47370 | |
| Pathway | KEGG_MEDICUS_VARIANT_TRK_FUSION_KINASE_TO_RAS_ERK_SIGNALING_PATHWAY | 1.31e-04 | 11 | 134 | 3 | M47371 | |
| Pathway | REACTOME_ACTIVATED_NTRK2_SIGNALS_THROUGH_FRS2_AND_FRS3 | 1.31e-04 | 11 | 134 | 3 | M27911 | |
| Pathway | REACTOME_MET_ACTIVATES_RAS_SIGNALING | 1.31e-04 | 11 | 134 | 3 | M27740 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_RAS_RALGDS_SIGNALING_PATHWAY | 1.31e-04 | 11 | 134 | 3 | M47436 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_RAS_RASSF1_SIGNALING_PATHWAY | 1.31e-04 | 11 | 134 | 3 | M47432 | |
| Pathway | WP_MAPK_CASCADE | 1.34e-04 | 28 | 134 | 4 | MM15976 | |
| Pathway | REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3 | KNTC1 TRIO OBSCN ARHGEF17 ERBIN PIK3C3 ARL13B KIF5A DNMBP FAM135A RGPD2 RANBP2 AHCTF1 MYH14 SCRIB SPEN ARHGAP45 | 1.40e-04 | 649 | 134 | 17 | MM15690 |
| Pathway | KEGG_MEDICUS_VARIANT_EML4_ALK_FUSION_KINASE_TO_RAS_ERK_SIGNALING_PATHWAY | 1.74e-04 | 12 | 134 | 3 | M47369 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_METALS_TO_RAS_ERK_SIGNALING_PATHWAY | 1.74e-04 | 12 | 134 | 3 | M47815 | |
| Pathway | REACTOME_SIGNALING_BY_PDGFRA_TRANSMEMBRANE_JUXTAMEMBRANE_AND_KINASE_DOMAIN_MUTANTS | 1.74e-04 | 12 | 134 | 3 | M29851 | |
| Pathway | WP_RALA_DOWNSTREAM_REGULATED_GENES | 1.74e-04 | 12 | 134 | 3 | M39408 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_RAS_JNK_SIGNALING_PATHWAY | 2.24e-04 | 13 | 134 | 3 | M47594 | |
| Pathway | REACTOME_P38MAPK_EVENTS | 2.24e-04 | 13 | 134 | 3 | M1441 | |
| Pathway | WP_MAPK_CASCADE | 2.58e-04 | 33 | 134 | 4 | M39594 | |
| Pathway | KEGG_MEDICUS_VARIANT_BCR_ABL_FUSION_KINASE_TO_RAS_ERK_SIGNALING_PATHWAY | 2.83e-04 | 14 | 134 | 3 | M47364 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_KIT_TO_RAS_ERK_SIGNALING_PATHWAY | 2.83e-04 | 14 | 134 | 3 | M47365 | |
| Pathway | KEGG_MEDICUS_VARIANT_DUPLICATION_OR_MUTATION_ACTIVATED_FLT3_TO_RAS_ERK_SIGNALING_PATHWAY | 2.83e-04 | 14 | 134 | 3 | M47366 | |
| Pathway | KEGG_MEDICUS_VARIANT_DUPLICATION_OR_MUTATION_ACTIVATED_FLT3_TO_RAS_PI3K_SIGNALING_PATHWAY | 2.83e-04 | 14 | 134 | 3 | M47390 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_PDGFR_TO_RAS_ERK_SIGNALING_PATHWAY | 2.83e-04 | 14 | 134 | 3 | M47378 | |
| Pathway | REACTOME_SHC1_EVENTS_IN_ERBB4_SIGNALING | 2.83e-04 | 14 | 134 | 3 | M569 | |
| Pathway | REACTOME_PTK6_REGULATES_RHO_GTPASES_RAS_GTPASE_AND_MAP_KINASES | 2.83e-04 | 14 | 134 | 3 | M27734 | |
| Pathway | KEGG_MEDICUS_VARIANT_MET_OVEREXPRESSION_TO_RAS_ERK_SIGNALING_PATHWAY | 2.83e-04 | 14 | 134 | 3 | M47488 | |
| Pathway | REACTOME_SHC1_EVENTS_IN_EGFR_SIGNALING | 2.83e-04 | 14 | 134 | 3 | M719 | |
| Pathway | PID_MAPK_TRK_PATHWAY | 2.90e-04 | 34 | 134 | 4 | M270 | |
| Pathway | REACTOME_RAF_ACTIVATION | 2.90e-04 | 34 | 134 | 4 | M27556 | |
| Pathway | WP_JAKSTAT_SIGNALING_IN_THE_REGULATION_OF_BETA_CELLS | 2.90e-04 | 34 | 134 | 4 | M48081 | |
| Pathway | KEGG_INSULIN_SIGNALING_PATHWAY | 3.31e-04 | 137 | 134 | 7 | M18155 | |
| Pathway | REACTOME_CONSTITUTIVE_SIGNALING_BY_EGFRVIII | 3.51e-04 | 15 | 134 | 3 | M29701 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_MET_TO_RAS_ERK_SIGNALING_PATHWAY | 3.51e-04 | 15 | 134 | 3 | M47367 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_RAS_PI3K_SIGNALING_PATHWAY | 3.51e-04 | 15 | 134 | 3 | M47389 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_EGFR_TO_RAS_ERK_SIGNALING_PATHWAY | 3.51e-04 | 15 | 134 | 3 | M47375 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_FGFR_TO_RAS_ERK_SIGNALING_PATHWAY | 3.51e-04 | 15 | 134 | 3 | M47380 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_PYK2_RAS_ERK_SIGNALING_PATHWAY | 3.51e-04 | 15 | 134 | 3 | M47592 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_FGF17_TO_RAS_ERK_SIGNALING_PATHWAY | 3.51e-04 | 15 | 134 | 3 | M47640 | |
| Pathway | KEGG_MEDICUS_VARIANT_IGF2_OVEREXPRESSION_TO_RAS_ERK_SIGNALING_PATHWAY | 3.51e-04 | 15 | 134 | 3 | M47485 | |
| Pathway | KEGG_MEDICUS_REFERENCE_HGF_MET_RAS_ERK_SIGNALING_PATHWAY | 3.51e-04 | 15 | 134 | 3 | M47473 | |
| Pathway | KEGG_MEDICUS_REFERENCE_FLT3LG_FLT3_RAS_ERK_SIGNALING_PATHWAY | 3.51e-04 | 15 | 134 | 3 | M47474 | |
| Pathway | KEGG_MEDICUS_REFERENCE_FLT3LG_FLT3_RAS_PI3K_SIGNALING_PATHWAY | 3.51e-04 | 15 | 134 | 3 | M47475 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TGFA_EGFR_RAS_ERK_SIGNALING_PATHWAY | 3.51e-04 | 15 | 134 | 3 | M47480 | |
| Pathway | KEGG_MEDICUS_VARIANT_EGF_OVEREXPRESSION_TO_RAS_ERK_SIGNALING_PATHWAY | 3.51e-04 | 15 | 134 | 3 | M47495 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EREG_EGFR_RAS_ERK_SIGNALING_PATHWAY | 3.51e-04 | 15 | 134 | 3 | M47496 | |
| Pathway | KEGG_MEDICUS_REFERENCE_AREG_EGFR_RAS_ERK_SIGNALING_PATHWAY | 3.51e-04 | 15 | 134 | 3 | M47497 | |
| Pathway | KEGG_MEDICUS_REFERENCE_KITLG_KIT_RAS_ERK_SIGNALING_PATHWAY | 3.51e-04 | 15 | 134 | 3 | M47472 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HCMV_GB_TO_PDGFR_RAS_ERK_SIGNALING_PATHWAY | 3.51e-04 | 15 | 134 | 3 | M47535 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E5_TO_EGFR_RAS_ERK_SIGNALING_PATHWAY | 3.51e-04 | 15 | 134 | 3 | M47531 | |
| Pathway | PID_CD8_TCR_DOWNSTREAM_PATHWAY | 3.77e-04 | 65 | 134 | 5 | M272 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_RAS_ERK_SIGNALING_PATHWAY | 4.30e-04 | 16 | 134 | 3 | M47363 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_FGFR3_TO_RAS_ERK_SIGNALING_PATHWAY | 4.30e-04 | 16 | 134 | 3 | M47373 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_ERBB2_RAS_ERK_SIGNALING_PATHWAY | 4.30e-04 | 16 | 134 | 3 | M47381 | |
| Pathway | KEGG_MEDICUS_REFERENCE_P4_PR_RAS_ERK_SIGNALING_PATHWAY | 4.30e-04 | 16 | 134 | 3 | M47804 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_E2_TO_RAS_ERK_SIGNALING_PATHWAY | 4.30e-04 | 16 | 134 | 3 | M47801 | |
| Pathway | REACTOME_GRB2_EVENTS_IN_ERBB2_SIGNALING | 4.30e-04 | 16 | 134 | 3 | M562 | |
| Pathway | REACTOME_SIGNALING_BY_FLT3_ITD_AND_TKD_MUTANTS | 4.30e-04 | 16 | 134 | 3 | M41733 | |
| Pathway | KEGG_MEDICUS_REFERENCE_AGE_RAGE_SIGNALING_PATHWAY | 4.30e-04 | 16 | 134 | 3 | M47682 | |
| Pathway | KEGG_MEDICUS_REFERENCE_IGF_IGF1R_RAS_ERK_SIGNALING_PATHWAY | 4.30e-04 | 16 | 134 | 3 | M47483 | |
| Pathway | REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3 | KNTC1 TRIO OBSCN ARHGEF17 ERBIN PIK3C3 ARL13B KIF5A DNMBP FAM135A RANBP2 AHCTF1 MYH14 KCTD3 SCRIB SPEN ARHGAP45 | 4.72e-04 | 720 | 134 | 17 | M41838 |
| Pathway | KEGG_MEDICUS_REFERENCE_PDGF_PDGFR_RAS_ERK_SIGNALING_PATHWAY | 5.18e-04 | 17 | 134 | 3 | M47376 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_AGE_RAGE_SIGNALING_PATHWAY | 5.18e-04 | 17 | 134 | 3 | M47684 | |
| Pathway | REACTOME_SIGNALING_BY_NTRK3_TRKC | 5.18e-04 | 17 | 134 | 3 | M27918 | |
| Pathway | REACTOME_SHC_MEDIATED_CASCADE_FGFR3 | 6.17e-04 | 18 | 134 | 3 | M27518 | |
| Pathway | WP_INHIBITION_OF_EXOSOME_BIOGENESIS_AND_SECRETION_BY_MANUMYCIN_A_IN_CRPC_CELLS | 6.17e-04 | 18 | 134 | 3 | M39737 | |
| Pathway | REACTOME_TIE2_SIGNALING | 6.17e-04 | 18 | 134 | 3 | M11932 | |
| Pathway | BIOCARTA_RANBP2_PATHWAY | 6.17e-04 | 18 | 134 | 3 | MM1549 | |
| Pathway | REACTOME_GASTRIN_CREB_SIGNALLING_PATHWAY_VIA_PKC_AND_MAPK | 6.17e-04 | 18 | 134 | 3 | M657 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1 | 6.86e-04 | 74 | 134 | 5 | M616 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_NNK_NNN_TO_RAS_ERK_SIGNALING_PATHWAY | 7.28e-04 | 19 | 134 | 3 | M47793 | |
| Pathway | REACTOME_CONSTITUTIVE_SIGNALING_BY_LIGAND_RESPONSIVE_EGFR_CANCER_VARIANTS | 7.28e-04 | 19 | 134 | 3 | M559 | |
| Pathway | REACTOME_VEGFR2_MEDIATED_CELL_PROLIFERATION | 7.28e-04 | 19 | 134 | 3 | M27423 | |
| Pathway | REACTOME_SIGNALING_BY_FLT3_FUSION_PROTEINS | 7.28e-04 | 19 | 134 | 3 | M41732 | |
| Pathway | BIOCARTA_EPO_PATHWAY | 7.28e-04 | 19 | 134 | 3 | M12836 | |
| Pathway | REACTOME_FRS_MEDIATED_FGFR3_SIGNALING | 8.50e-04 | 20 | 134 | 3 | M27519 | |
| Pathway | REACTOME_SHC_MEDIATED_CASCADE_FGFR4 | 8.50e-04 | 20 | 134 | 3 | M27524 | |
| Pathway | BIOCARTA_EPO_PATHWAY | 8.50e-04 | 20 | 134 | 3 | MM1389 | |
| Pathway | REACTOME_RAS_ACTIVATION_UPON_CA2_INFLUX_THROUGH_NMDA_RECEPTOR | 8.50e-04 | 20 | 134 | 3 | M17670 | |
| Pathway | REACTOME_SIGNALING_BY_KIT_IN_DISEASE | 8.50e-04 | 20 | 134 | 3 | M39002 | |
| Pathway | REACTOME_SIGNALLING_TO_RAS | 8.50e-04 | 20 | 134 | 3 | M12256 | |
| Pathway | WP_AUTOPHAGY_IN_PANCREATIC_DUCTAL_ADENOCARCINOMA | 8.50e-04 | 20 | 134 | 3 | M48066 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | LRWD1 ACACA TRIO INPPL1 SREBF1 OBSCN TMCO6 ATG2A TBC1D24 MDN1 LRRC56 AP1G2 DENND5A HERC2 DNMBP CRAMP1 MED13 BAHCC1 MRPL21 KMT5C FRYL SMG5 REV3L MAP1S PRKDC ZNF839 SPEN | 1.20e-10 | 1105 | 193 | 27 | 35748872 |
| Pubmed | CYLD HDAC9 CAND1 TRIO SACS NFE2L2 GLUD1 ARL13B KIF5A HERC2 UTRN MED13 DMXL2 ITCH SUPT20H APBA2 SMG5 CLIC6 REV3L VPS9D1 FRY FBXL16 MAP1S MYH14 TNKS PRKDC SCRIB CKAP2 PADI2 | 1.48e-10 | 1285 | 193 | 29 | 35914814 | |
| Pubmed | 9.19e-10 | 4 | 193 | 4 | 9674433 | ||
| Pubmed | Quantification of spatiotemporal patterns of Ras isoform expression during development. | 9.19e-10 | 4 | 193 | 4 | 28117393 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | CYLD HDAC4 ACACA TRIO INPPL1 ARHGEF17 ERBIN MDN1 NFATC3 PIK3C3 DNMBP UTRN DIP2B ITCH ROR2 FRYL NEURL1 FAM53B SRPK3 SCRIB CKAP2 PARD3 | 3.21e-09 | 861 | 193 | 22 | 36931259 |
| Pubmed | CYLD CAND1 HDAC4 TRIO TRPC4 ERBIN DLGAP3 MDN1 NFATC3 ANAPC1 HRAS KIF5A HERC2 KRAS DIP2B RGPD2 RANBP2 DMXL2 ITCH FRY TNKS SCRIB PARD3 | 4.89e-09 | 963 | 193 | 23 | 28671696 | |
| Pubmed | 9.60e-09 | 14 | 193 | 5 | 15964851 | ||
| Pubmed | 3.18e-08 | 7 | 193 | 4 | 20179099 | ||
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | HDAC4 TRIO INPP4A CDAN1 HERC2 DIP2B RANBP2 SMG5 ACAD10 SHOC2 PPM1G FRY TNKS PARD3 SNRPA1 | 7.88e-08 | 475 | 193 | 15 | 31040226 |
| Pubmed | 1.13e-07 | 9 | 193 | 4 | 10783161 | ||
| Pubmed | 1.13e-07 | 9 | 193 | 4 | 9344703 | ||
| Pubmed | Diagnostic Value of RAS Mutations in Indeterminate Thyroid Nodules. | 1.68e-07 | 3 | 193 | 3 | 28116986 | |
| Pubmed | Mutations of RAS gene family in specimens of bladder cancer. | 1.68e-07 | 3 | 193 | 3 | 19101897 | |
| Pubmed | 1.68e-07 | 3 | 193 | 3 | 33620658 | ||
| Pubmed | 1.68e-07 | 3 | 193 | 3 | 22589270 | ||
| Pubmed | A requirement for wild-type Ras isoforms in mutant KRas-driven signalling and transformation. | 1.68e-07 | 3 | 193 | 3 | 23496764 | |
| Pubmed | Distribution of p21ras during primary palate formation of non-cleft and cleft strains of mice. | 1.68e-07 | 3 | 193 | 3 | 7776260 | |
| Pubmed | 1.68e-07 | 3 | 193 | 3 | 25788415 | ||
| Pubmed | Comparison of liver oncogenic potential among human RAS isoforms. | 1.68e-07 | 3 | 193 | 3 | 26799184 | |
| Pubmed | 1.68e-07 | 3 | 193 | 3 | 31906952 | ||
| Pubmed | Partial functional overlap of the three ras genes in mouse embryonic development. | 1.68e-07 | 3 | 193 | 3 | 18059342 | |
| Pubmed | Evidence of a low prevalence of RAS mutations in a large medullary thyroid cancer series. | 1.68e-07 | 3 | 193 | 3 | 23240926 | |
| Pubmed | Absolute Quantification of Endogenous Ras Isoform Abundance. | 1.68e-07 | 3 | 193 | 3 | 26560143 | |
| Pubmed | Further evidence for a somatic KRAS mutation in a pilocytic astrocytoma. | 1.68e-07 | 3 | 193 | 3 | 17712732 | |
| Pubmed | 1.68e-07 | 3 | 193 | 3 | 24222113 | ||
| Pubmed | Interactions between wild-type and mutant Ras genes in lung and skin carcinogenesis. | 1.68e-07 | 3 | 193 | 3 | 22945650 | |
| Pubmed | 1.68e-07 | 3 | 193 | 3 | 19303097 | ||
| Pubmed | 1.68e-07 | 3 | 193 | 3 | 27911734 | ||
| Pubmed | Absence of oncogenic mutations of RAS family genes in soft tissue sarcomas of 100 Japanese patients. | 1.68e-07 | 3 | 193 | 3 | 20150643 | |
| Pubmed | K-ras is an essential gene in the mouse with partial functional overlap with N-ras. | 1.68e-07 | 3 | 193 | 3 | 9334313 | |
| Pubmed | RAS gene mutations and histomorphometric measurements in oral squamous cell carcinoma. | 1.68e-07 | 3 | 193 | 3 | 37013448 | |
| Pubmed | 1.68e-07 | 3 | 193 | 3 | 25977330 | ||
| Pubmed | 1.68e-07 | 3 | 193 | 3 | 28630043 | ||
| Pubmed | Overexpression of wild-type p21Ras plays a prominent role in colorectal cancer. | 1.68e-07 | 3 | 193 | 3 | 28259994 | |
| Pubmed | The variable phenotype and low-risk nature of RAS-positive thyroid nodules. | 1.68e-07 | 3 | 193 | 3 | 26253102 | |
| Pubmed | 1.68e-07 | 3 | 193 | 3 | 16573741 | ||
| Pubmed | Analysis of k-ras nuclear expression in fibroblasts and mesangial cells. | 1.68e-07 | 3 | 193 | 3 | 20090846 | |
| Pubmed | 1.68e-07 | 3 | 193 | 3 | 21737741 | ||
| Pubmed | 1.68e-07 | 3 | 193 | 3 | 17943694 | ||
| Pubmed | 1.68e-07 | 3 | 193 | 3 | 28202657 | ||
| Pubmed | Mutational analysis of K-ras and Ras protein expression in larynx squamous cell carcinoma. | 1.68e-07 | 3 | 193 | 3 | 16761621 | |
| Pubmed | 1.68e-07 | 3 | 193 | 3 | 20971740 | ||
| Pubmed | 1.68e-07 | 3 | 193 | 3 | 27119512 | ||
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | 2.17e-07 | 202 | 193 | 10 | 33005030 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | MYD88 CAND1 HDAC4 ACACA TRIO INPP4A NAIP OBSCN ERBIN INTS2 PIK3C3 TXNL4B DENND5A UTRN CRAMP1 DIP2B ITCH GNL3L ROR2 ZBTB8A FRYL GTF3C1 MYH14 CKAP2 PARD3 ZNF839 | 2.47e-07 | 1489 | 193 | 26 | 28611215 |
| Pubmed | HAUS6 ERBIN DNMBP UTRN FAM135A RANBP2 AHCTF1 ROR2 APBA2 SCRIB PARD3 | 2.90e-07 | 263 | 193 | 11 | 34702444 | |
| Pubmed | 2.97e-07 | 209 | 193 | 10 | 36779422 | ||
| Pubmed | CAND1 ACACA FANCD2 PARP4 MDN1 ANAPC1 GLUD1 HERC2 VPS51 RANBP2 GNL3L TOR2A CIP2A PPM1G MAP1S DHX32 | 3.24e-07 | 606 | 193 | 16 | 36538041 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | LRWD1 ACACA ERBIN BLM FANCD2 MDN1 ANAPC1 DNMBP MED13 DIP2B RANBP2 GTF3C1 MAP1S SHCBP1 PRKDC SCRIB PARD3 SPEN | 3.72e-07 | 774 | 193 | 18 | 15302935 |
| Pubmed | ZC3H14 HAUS6 ERBIN FANCD2 UTRN RGPD2 CIP2A PPM1G GTF3C1 SCRIB | 3.86e-07 | 215 | 193 | 10 | 35973513 | |
| Pubmed | 4.39e-07 | 12 | 193 | 4 | 9269777 | ||
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | CAND1 NHLRC2 FANCD2 DLGAP3 FBN2 GLUD1 KIF5A DMD UTRN DIP2B RANBP2 CIP2A PPM1G GTF3C1 SHCBP1 KCTD3 TNKS PRKDC SNRPA1 PADI2 | 5.78e-07 | 974 | 193 | 20 | 28675297 |
| Pubmed | 6.70e-07 | 4 | 193 | 3 | 10085069 | ||
| Pubmed | 6.70e-07 | 4 | 193 | 3 | 38849523 | ||
| Pubmed | 6.70e-07 | 4 | 193 | 3 | 28095473 | ||
| Pubmed | The RAS-Effector Interface: Isoform-Specific Differences in the Effector Binding Regions. | 6.70e-07 | 4 | 193 | 3 | 27936046 | |
| Pubmed | Reducing Pericyte-Derived Scarring Promotes Recovery after Spinal Cord Injury. | 6.70e-07 | 4 | 193 | 3 | 29502968 | |
| Pubmed | Activated Ras interacts with the Ral guanine nucleotide dissociation stimulator. | 6.70e-07 | 4 | 193 | 3 | 7972015 | |
| Pubmed | 6.70e-07 | 4 | 193 | 3 | 10490827 | ||
| Pubmed | Tyrosine phosphorylation of RAS by ABL allosterically enhances effector binding. | 6.70e-07 | 4 | 193 | 3 | 25999467 | |
| Pubmed | 6.70e-07 | 4 | 193 | 3 | 34948093 | ||
| Pubmed | Ras membrane orientation and nanodomain localization generate isoform diversity. | 6.70e-07 | 4 | 193 | 3 | 20080631 | |
| Pubmed | Erbin inhibits RAF activation by disrupting the sur-8-Ras-Raf complex. | 6.70e-07 | 4 | 193 | 3 | 16301319 | |
| Pubmed | CYLD HAUS6 ERBIN CDAN1 KIF5A MED7 UTRN MED13 GNL3L SUPT20H CIP2A PPM1G MYH14 SCRIB CKAP2 SPEN | 7.36e-07 | 645 | 193 | 16 | 25281560 | |
| Pubmed | ACACA TRIO INPPL1 ERBIN TBC1D24 ARL13B DMD UTRN FAM135A ITCH ROR2 SCRIB PARD3 | 7.64e-07 | 421 | 193 | 13 | 36976175 | |
| Pubmed | FAM114A1 TRIO OBSCN PARP4 CLIC5 UTRN MED13 RANBP2 DMXL2 ITCH MYH14 TNKS MYOM2 PARD3 | 8.47e-07 | 497 | 193 | 14 | 23414517 | |
| Pubmed | 1.50e-06 | 100 | 193 | 7 | 10048485 | ||
| Pubmed | Comparative interactome analysis of α-arrestin families in human and Drosophila. | ZC3H14 FANCD2 HERC2 DMD UTRN ITCH ARRDC5 GTF3C1 SCRIB PARD3 SPEN | 1.60e-06 | 313 | 193 | 11 | 38270169 |
| Pubmed | 1.67e-06 | 5 | 193 | 3 | 22982107 | ||
| Pubmed | 1.67e-06 | 5 | 193 | 3 | 17540175 | ||
| Pubmed | 1.67e-06 | 5 | 193 | 3 | 9069260 | ||
| Pubmed | Pericyte-derived fibrotic scarring is conserved across diverse central nervous system lesions. | 1.67e-06 | 5 | 193 | 3 | 34535655 | |
| Pubmed | Impeded Nedd4-1-mediated Ras degradation underlies Ras-driven tumorigenesis. | 1.67e-06 | 5 | 193 | 3 | 24746824 | |
| Pubmed | Activated Ras induces lens epithelial cell hyperplasia but not premature differentiation. | 1.67e-06 | 5 | 193 | 3 | 15558479 | |
| Pubmed | 1.67e-06 | 5 | 193 | 3 | 24166518 | ||
| Pubmed | KNTC1 FAM114A1 FAM114A2 ERBIN MDN1 SACS GLUD1 PKHD1 DLEC1 KIF5A DMD MED13 BAHCC1 RGPD2 RANBP2 MYH7B HKDC1 CAPN11 GTF3C1 MYH14 MYOM2 PRKDC SPEN PCK1 | 1.72e-06 | 1442 | 193 | 24 | 35575683 | |
| Pubmed | Stress-Activated NRF2-MDM2 Cascade Controls Neoplastic Progression in Pancreas. | 3.32e-06 | 6 | 193 | 3 | 29153842 | |
| Pubmed | Glutamate transporter Slc1a3 mediates inter-niche stem cell activation during skin growth. | 3.32e-06 | 6 | 193 | 3 | 29615452 | |
| Pubmed | 3.32e-06 | 6 | 193 | 3 | 30865892 | ||
| Pubmed | 3.32e-06 | 6 | 193 | 3 | 9753431 | ||
| Pubmed | 3.32e-06 | 6 | 193 | 3 | 21072204 | ||
| Pubmed | 3.32e-06 | 6 | 193 | 3 | 10882715 | ||
| Pubmed | LZTR1 facilitates polyubiquitination and degradation of RAS-GTPases. | 3.32e-06 | 6 | 193 | 3 | 31337872 | |
| Pubmed | 3.34e-06 | 19 | 193 | 4 | 21965329 | ||
| Pubmed | ZC3H14 ACACA BLM MDN1 ANAPC1 HERC2 UTRN RANBP2 AHCTF1 FRYL PPM1G GTF3C1 MYH14 PRKDC SPEN | 4.20e-06 | 653 | 193 | 15 | 22586326 | |
| Pubmed | 5.79e-06 | 7 | 193 | 3 | 20526288 | ||
| Pubmed | 5.79e-06 | 7 | 193 | 3 | 20012784 | ||
| Pubmed | The SUMO E3 ligase RanBP2 promotes modification of the HDAC4 deacetylase. | 5.79e-06 | 7 | 193 | 3 | 12032081 | |
| Pubmed | Impaired Proteolysis of Noncanonical RAS Proteins Drives Clonal Hematopoietic Transformation. | 5.79e-06 | 7 | 193 | 3 | 35904492 | |
| Pubmed | SmgGDS displays differential binding and exchange activity towards different Ras isoforms. | 5.79e-06 | 7 | 193 | 3 | 11948427 | |
| Pubmed | 5.79e-06 | 7 | 193 | 3 | 20860430 | ||
| Pubmed | 5.79e-06 | 7 | 193 | 3 | 22199277 | ||
| Pubmed | 5.79e-06 | 7 | 193 | 3 | 19487299 | ||
| Pubmed | 5.79e-06 | 7 | 193 | 3 | 9690470 | ||
| Pubmed | Mouse screen reveals multiple new genes underlying mouse and human hearing loss. | MYD88 PRRG2 ZC3H14 NHLRC2 PRAMEF2 TRIM11 MDN1 INTS2 VPS51 IL23R DIP2B DMXL2 MYH7B ARRDC5 PRAMEF12 FRYL CAPN11 ATXN3L MYH14 MX1 CRB2 | 6.32e-06 | 1242 | 193 | 21 | 30973865 |
| Pubmed | TRIO ERBIN BLM FANCD2 TRIM11 ARL13B HERC2 DMD UTRN RANBP2 CIP2A BAG5 SHOC2 PPM1G FBXL16 KCTD3 SCRIB CKAP2 FBXW7 | 6.87e-06 | 1049 | 193 | 19 | 27880917 | |
| Pubmed | Cand1 promotes assembly of new SCF complexes through dynamic exchange of F box proteins. | 9.23e-06 | 8 | 193 | 3 | 23453757 | |
| Pubmed | Genetic analysis of Ras signalling pathways in cell proliferation, migration and survival. | 9.23e-06 | 8 | 193 | 3 | 20150892 | |
| Pubmed | Toll-Like Receptors Induce Signal-Specific Reprogramming of the Macrophage Lipidome. | 9.23e-06 | 8 | 193 | 3 | 32516576 | |
| Pubmed | 9.23e-06 | 8 | 193 | 3 | 15064703 | ||
| Interaction | ELMOD3 interactions | 2.84e-07 | 16 | 190 | 5 | int:ELMOD3 | |
| Interaction | HDAC4 interactions | HDAC9 HDAC4 ACACA TRIO INPP4A CDAN1 CIITA HRAS HERC2 DIP2B RANBP2 SMG5 ACAD10 REV3L SHOC2 PPM1G FRY MAP1S KCTD3 TNKS PARD3 SNRPA1 | 2.19e-06 | 744 | 190 | 22 | int:HDAC4 |
| Interaction | SHOC2 interactions | 6.26e-06 | 74 | 190 | 7 | int:SHOC2 | |
| Interaction | DCUN1D3 interactions | 6.98e-06 | 29 | 190 | 5 | int:DCUN1D3 | |
| Interaction | LZTR1 interactions | 1.04e-05 | 111 | 190 | 8 | int:LZTR1 | |
| Interaction | UNC5B interactions | 1.46e-05 | 84 | 190 | 7 | int:UNC5B | |
| Interaction | HEPH interactions | 1.62e-05 | 6 | 190 | 3 | int:HEPH | |
| Interaction | CEP104 interactions | 2.13e-05 | 89 | 190 | 7 | int:CEP104 | |
| Interaction | LRRC31 interactions | 2.59e-05 | 205 | 190 | 10 | int:LRRC31 | |
| Interaction | NOXO1 interactions | 2.66e-05 | 19 | 190 | 4 | int:NOXO1 | |
| Interaction | PARD3 interactions | CYLD HDAC4 TRIO ERBIN ARL13B HRAS DNMBP UTRN KRAS ROR2 SCRIB PARD3 | 2.74e-05 | 298 | 190 | 12 | int:PARD3 |
| Interaction | TACSTD2 interactions | 3.10e-05 | 129 | 190 | 8 | int:TACSTD2 | |
| Interaction | RP2 interactions | 3.25e-05 | 95 | 190 | 7 | int:RP2 | |
| Interaction | GSK3A interactions | CYLD ZC3H14 ACACA TRIO INPPL1 ERBIN MDN1 GLUD1 DDHD2 UTRN STON1 CIP2A ROR2 PRKDC SCRIB | 3.60e-05 | 464 | 190 | 15 | int:GSK3A |
| Interaction | NPY2R interactions | 3.69e-05 | 66 | 190 | 6 | int:NPY2R | |
| Interaction | ICMT interactions | 4.02e-05 | 67 | 190 | 6 | int:ICMT | |
| Interaction | JAG1 interactions | 4.02e-05 | 41 | 190 | 5 | int:JAG1 | |
| Interaction | FLOT1 interactions | TRIO ERBIN FANCD2 NFATC3 GLUD1 ARL13B HRAS UTRN FAM135A KRAS DIP2B NRAS ROR2 SCRIB PARD3 | 4.69e-05 | 475 | 190 | 15 | int:FLOT1 |
| Interaction | NECTIN1 interactions | 4.90e-05 | 22 | 190 | 4 | int:NECTIN1 | |
| Interaction | C5orf15 interactions | 4.90e-05 | 22 | 190 | 4 | int:C5orf15 | |
| Interaction | UBE2S interactions | 5.03e-05 | 138 | 190 | 8 | int:UBE2S | |
| Interaction | RNF43 interactions | EPOR HAUS6 OBSCN ERBIN DNMBP UTRN FAM135A RANBP2 AHCTF1 ROR2 BAG5 APBA2 SCRIB PARD3 | 5.66e-05 | 427 | 190 | 14 | int:RNF43 |
| Interaction | MARK2 interactions | 6.10e-05 | 274 | 190 | 11 | int:MARK2 | |
| Interaction | MCL1 interactions | 6.80e-05 | 144 | 190 | 8 | int:MCL1 | |
| Interaction | NPTN interactions | KNTC1 FANCD2 FANCG MDN1 HRAS VPS51 DMXL2 CIP2A ACAD10 BRINP2 PRAME | 6.95e-05 | 278 | 190 | 11 | int:NPTN |
| Interaction | SLCO4A1 interactions | 7.08e-05 | 46 | 190 | 5 | int:SLCO4A1 | |
| Interaction | GSK3B interactions | CYLD HDAC4 ACACA TRIO INPPL1 SREBF1 NHLRC2 ERBIN CIITA NFE2L2 DDHD2 HERC2 VPS51 UTRN STON1 CIP2A ROR2 SRPK3 PRKDC SCRIB FBXW7 | 7.43e-05 | 868 | 190 | 21 | int:GSK3B |
| Interaction | EPHA7 interactions | TRIO ERBIN GLUD1 HERC2 FAM135A KRAS DIP2B NRAS ROR2 SCRIB PARD3 | 7.89e-05 | 282 | 190 | 11 | int:EPHA7 |
| Interaction | RALGAPA2 interactions | 8.71e-05 | 48 | 190 | 5 | int:RALGAPA2 | |
| Interaction | ZFPL1 interactions | TRIO ERBIN FANCD2 PIK3C3 ARL13B HRAS VPS51 UTRN FAM135A KRAS NRAS ROR2 SCRIB PARD3 | 9.42e-05 | 448 | 190 | 14 | int:ZFPL1 |
| Interaction | TRPV2 interactions | 9.43e-05 | 10 | 190 | 3 | int:TRPV2 | |
| Interaction | LRRC27 interactions | 9.73e-05 | 26 | 190 | 4 | int:LRRC27 | |
| Interaction | YAP1 interactions | PRRG2 ZC3H14 CAND1 ACACA ERBIN YOD1 TRIM11 ANAPC1 MYO3B KIF5A KRAS ITCH AHCTF1 BAG5 PPID TGM2 GTF3C1 MYH14 PRKDC SCRIB PARD3 SPEN ARHGAP45 FBXW7 | 1.04e-04 | 1095 | 190 | 24 | int:YAP1 |
| Interaction | TOP3A interactions | 1.04e-04 | 114 | 190 | 7 | int:TOP3A | |
| Interaction | RASSF5 interactions | 1.28e-04 | 52 | 190 | 5 | int:RASSF5 | |
| Interaction | GJA1 interactions | TRIO ERBIN PIK3C3 ARL13B VPS51 UTRN FAM135A DENND5B KRAS ITCH NRAS ROR2 PPM1G TGM2 SCRIB PARD3 | 1.36e-04 | 583 | 190 | 16 | int:GJA1 |
| Interaction | SLC1A3 interactions | 1.53e-04 | 85 | 190 | 6 | int:SLC1A3 | |
| Interaction | RALGPS2 interactions | 1.54e-04 | 54 | 190 | 5 | int:RALGPS2 | |
| Interaction | ANXA1 interactions | INPPL1 PRAMEF2 FANCD2 HRAS KRAS NRAS SHOC2 TGM2 MAP1S SRPK3 FBXW7 | 1.62e-04 | 306 | 190 | 11 | int:ANXA1 |
| Interaction | EPHA2 interactions | ACACA TRIO INPPL1 ERBIN TBC1D24 FANCD2 ARL13B HRAS DMD UTRN FAM135A KRAS FLT4 ITCH NRAS ROR2 SCRIB PARD3 | 1.63e-04 | 719 | 190 | 18 | int:EPHA2 |
| Interaction | LYN interactions | EPOR TRIO INPPL1 ERBIN FANCD2 ARL13B HRAS DMD UHRF2 UTRN FAM135A KRAS NRAS ROR2 DENND2C PRKDC SCRIB PARD3 | 1.66e-04 | 720 | 190 | 18 | int:LYN |
| Interaction | EFNB3 interactions | 1.68e-04 | 55 | 190 | 5 | int:EFNB3 | |
| Interaction | OPALIN interactions | 1.70e-04 | 209 | 190 | 9 | int:OPALIN | |
| Interaction | ZNF563 interactions | 1.70e-04 | 12 | 190 | 3 | int:ZNF563 | |
| Interaction | GTSF1 interactions | 1.70e-04 | 12 | 190 | 3 | int:GTSF1 | |
| Interaction | C11orf52 interactions | TRIO ERBIN ARL13B HRAS UTRN FAM135A DIP2B ITCH ROR2 SCRIB PARD3 | 1.86e-04 | 311 | 190 | 11 | int:C11orf52 |
| Interaction | FAM234A interactions | 1.95e-04 | 126 | 190 | 7 | int:FAM234A | |
| Interaction | DCUN1D2 interactions | 1.97e-04 | 31 | 190 | 4 | int:DCUN1D2 | |
| Interaction | JAM3 interactions | 1.97e-04 | 31 | 190 | 4 | int:JAM3 | |
| Interaction | LIPH interactions | 2.16e-04 | 58 | 190 | 5 | int:LIPH | |
| Interaction | RASGRP2 interactions | 2.20e-04 | 13 | 190 | 3 | int:RASGRP2 | |
| Interaction | RCE1 interactions | 2.20e-04 | 13 | 190 | 3 | int:RCE1 | |
| Interaction | MEAK7 interactions | 2.24e-04 | 32 | 190 | 4 | int:MEAK7 | |
| Interaction | PIK3CG interactions | 2.34e-04 | 59 | 190 | 5 | int:PIK3CG | |
| Interaction | ZUP1 interactions | 2.52e-04 | 174 | 190 | 8 | int:ZUP1 | |
| Interaction | MARVELD2 interactions | 2.54e-04 | 60 | 190 | 5 | int:MARVELD2 | |
| Interaction | PSMD2 interactions | CYLD HDAC4 ACACA NHLRC2 FANCD2 TRIM11 HERC2 KRAS BAG5 PPM1G VPS9D1 TGM2 PCK1 | 2.59e-04 | 435 | 190 | 13 | int:PSMD2 |
| Interaction | KIAA1210 interactions | 2.64e-04 | 3 | 190 | 2 | int:KIAA1210 | |
| Interaction | UBXN6 interactions | KNTC1 DNAL1 YOD1 MDN1 ANAPC1 HRAS DNMBP KRAS GTF3C1 MAP1S PRKDC | 2.72e-04 | 325 | 190 | 11 | int:UBXN6 |
| Interaction | ITGB6 interactions | 2.78e-04 | 14 | 190 | 3 | int:ITGB6 | |
| Interaction | TMA16 interactions | 2.81e-04 | 95 | 190 | 6 | int:TMA16 | |
| Interaction | TOP3B interactions | LRWD1 HDAC4 ACACA TRIO INPPL1 SREBF1 OBSCN TMCO6 ATG2A TBC1D24 MDN1 LRRC56 AP1G2 DENND5A HERC2 DNMBP CRAMP1 MED13 BAHCC1 MRPL21 KMT5C FRYL SMG5 REV3L MAP1S PRKDC ZNF839 SPEN | 2.87e-04 | 1470 | 190 | 28 | int:TOP3B |
| Interaction | SFN interactions | CYLD HDAC9 HDAC4 ARHGEF17 ERBIN FANCD2 NFATC3 DNMBP KRAS ITCH ROR2 FRYL SHCBP1 FAM53B SCRIB PARD3 FBXW7 | 3.10e-04 | 692 | 190 | 17 | int:SFN |
| Interaction | SLC2A3 interactions | 3.19e-04 | 35 | 190 | 4 | int:SLC2A3 | |
| Interaction | SNTB1 interactions | 3.19e-04 | 63 | 190 | 5 | int:SNTB1 | |
| Interaction | MAPK10 interactions | 3.19e-04 | 63 | 190 | 5 | int:MAPK10 | |
| Interaction | PLCB1 interactions | 3.19e-04 | 63 | 190 | 5 | int:PLCB1 | |
| Interaction | CLEC16A interactions | CAND1 ACACA FANCD2 PARP4 MDN1 ANAPC1 GLUD1 HERC2 VPS51 RANBP2 GNL3L TOR2A CIP2A PPM1G MAP1S DHX32 | 3.19e-04 | 629 | 190 | 16 | int:CLEC16A |
| Interaction | SNX5 interactions | 3.25e-04 | 137 | 190 | 7 | int:SNX5 | |
| Interaction | AFDN interactions | ERBIN ARL13B HRAS DNMBP UTRN KRAS NRAS ROR2 KCTD3 SCRIB PARD3 | 3.35e-04 | 333 | 190 | 11 | int:AFDN |
| Interaction | MED4 interactions | CYLD HAUS6 ERBIN KIF5A HERC2 MED7 UTRN MED13 KRAS CIP2A PPM1G SCRIB FBXW7 | 3.58e-04 | 450 | 190 | 13 | int:MED4 |
| Interaction | LUC7L3 interactions | 3.80e-04 | 185 | 190 | 8 | int:LUC7L3 | |
| Cytoband | 16q22.2 | 1.08e-04 | 22 | 194 | 3 | 16q22.2 | |
| GeneFamily | RAS type GTPase family | 6.50e-05 | 31 | 128 | 4 | 389 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 2.62e-04 | 18 | 128 | 3 | 91 | |
| GeneFamily | Histone deacetylases, class IIA | 2.96e-04 | 4 | 128 | 2 | 992 | |
| GeneFamily | F-box and leucine rich repeat proteins | 4.20e-04 | 21 | 128 | 3 | 558 | |
| GeneFamily | PRAME family | 6.29e-04 | 24 | 128 | 3 | 686 | |
| GeneFamily | Guanylate cyclase receptors|DENN/MADD domain containing | 7.11e-04 | 25 | 128 | 3 | 504 | |
| GeneFamily | Chloride intracellular channels | 7.32e-04 | 6 | 128 | 2 | 307 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 1.23e-03 | 66 | 128 | 4 | 722 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | ZC3H14 CAND1 HDAC4 TRIO BLM MDN1 SACS NFATC3 PIK3C3 DENND5A DMD DNMBP MED13 RANBP2 DMXL2 ITCH SUPT20H AHCTF1 FRYL REV3L SHOC2 TNKS PARD3 SPEN | 1.62e-08 | 856 | 190 | 24 | M4500 |
| Coexpression | GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_UP | DPH7 TBC1D24 TRIM11 NFATC3 GLUD1 HRAS LRRC56 UTRN NANOS1 TOR2A EOLA1 ZBTB8A EOLA2 TGM2 CKAP2 FBXL20 PADI2 MX1 | 1.26e-06 | 647 | 190 | 18 | MM981 |
| Coexpression | PILON_KLF1_TARGETS_UP | CYLD KNTC1 FAM114A1 TRIO FBN2 DDHD2 MED13 FLT4 GNL3L MYH7B ABCC9 FRYL SHOC2 TMEM132D DENND2C | 4.37e-06 | 503 | 190 | 15 | M2226 |
| Coexpression | DING_LUNG_CANCER_MUTATED_RECURRENTLY | 7.38e-06 | 6 | 190 | 3 | M14019 | |
| Coexpression | PILON_KLF1_TARGETS_UP | CYLD KNTC1 FAM114A1 TRIO FBN2 DDHD2 MED13 FLT4 GNL3L MYH7B ABCC9 FRYL SHOC2 TMEM132D DENND2C | 1.04e-05 | 541 | 190 | 15 | MM1061 |
| Coexpression | GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_UP | DPH7 TBC1D24 TRIM11 NFATC3 GLUD1 HRAS LRRC56 UTRN NANOS1 TOR2A EOLA1 ZBTB8A TGM2 CKAP2 FBXL20 PADI2 | 1.07e-05 | 611 | 190 | 16 | M1106 |
| Coexpression | GSE360_L_MAJOR_VS_B_MALAYI_LOW_DOSE_MAC_DN | 1.57e-05 | 199 | 190 | 9 | M5251 | |
| Coexpression | GSE41867_DAY15_EFFECTOR_VS_DAY30_MEMORY_CD8_TCELL_LCMV_ARMSTRONG_DN | 7.76e-05 | 190 | 190 | 8 | M9521 | |
| Coexpression | PYEON_CANCER_HEAD_AND_NECK_VS_CERVICAL_UP | 9.30e-05 | 195 | 190 | 8 | M13736 | |
| Coexpression | PUJANA_BREAST_CANCER_LIT_INT_NETWORK | 9.60e-05 | 101 | 190 | 6 | M15356 | |
| Coexpression | GSE32533_WT_VS_MIR17_KO_ACT_CD4_TCELL_DN | 9.99e-05 | 197 | 190 | 8 | M8464 | |
| Coexpression | BROWNE_HCMV_INFECTION_20HR_DN | 1.01e-04 | 102 | 190 | 6 | M5601 | |
| Coexpression | GSE3982_MAST_CELL_VS_TH1_DN | 1.03e-04 | 198 | 190 | 8 | M5454 | |
| Coexpression | GSE41978_ID2_KO_VS_BIM_KO_KLRG1_LOW_EFFECTOR_CD8_TCELL_UP | 1.07e-04 | 199 | 190 | 8 | M9568 | |
| Coexpression | GSE2405_HEAT_KILLED_VS_LIVE_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_24H_UP | 1.07e-04 | 199 | 190 | 8 | M6218 | |
| Coexpression | GSE1432_CTRL_VS_IFNG_24H_MICROGLIA_DN | 1.11e-04 | 200 | 190 | 8 | M3408 | |
| Coexpression | GSE17721_POLYIC_VS_PAM3CSK4_2H_BMDC_UP | 1.11e-04 | 200 | 190 | 8 | M3830 | |
| Coexpression | GSE5142_HTERT_TRANSDUCED_VS_CTRL_CD8_TCELL_LATE_PASSAGE_CLONE_DN | 1.11e-04 | 200 | 190 | 8 | M6552 | |
| Coexpression | GRESHOCK_CANCER_COPY_NUMBER_UP | 1.32e-04 | 323 | 190 | 10 | M9150 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.22e-07 | 184 | 194 | 9 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.22e-07 | 184 | 194 | 9 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.22e-07 | 184 | 194 | 9 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_airway-epi_proximal_secretory_(0)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.83e-07 | 193 | 194 | 9 | b38aaffbea36ef6c08ebe82675438f873c89b242 | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.23e-06 | 179 | 194 | 8 | a1ea8daa0fe8900f5a04b555c77fe8ebdaa3908d | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.78e-06 | 188 | 194 | 8 | 43a3a59f92ad93509d4166bd025aed0b1b39a008 | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.78e-06 | 188 | 194 | 8 | 0d86044bc340e3efb90d0022dd299873639d831c | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.78e-06 | 188 | 194 | 8 | 63a4b25a0a6e05f80f1a6dd91b817f3cf49e6b68 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.85e-06 | 189 | 194 | 8 | 7659c7bbd58ee959a159294fb8d17317bbcc5681 | |
| ToppCell | COVID-19-Heart|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.92e-06 | 190 | 194 | 8 | 918ad5037881212008f9f69d5df5da91fd01422c | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_secretory_(0)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.00e-06 | 191 | 194 | 8 | 60ff989fe99d243a3d52955223680cdd1f1917a4 | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_neuroendo-epi_NE_progenitor_(7)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.00e-06 | 191 | 194 | 8 | 63aa671837b79d2feb7ed1e67712cc01caf72bef | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_airway-epi_proximal_progenitor2_(4)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.08e-06 | 192 | 194 | 8 | c15841f35e24d6ef6ce2a9a6dc62e66efdc3d9d5 | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 2.16e-06 | 193 | 194 | 8 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_progenitor2_(4)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.24e-06 | 194 | 194 | 8 | 6b286992d4bb56013c0ea5a7601d3476d806175a | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_alveolar-distal-epi_CTGF^high_distal_(3)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.24e-06 | 194 | 194 | 8 | c5ef4ff73b4e51530656002e3a2fb7264cdf533d | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_airway|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.24e-06 | 194 | 194 | 8 | 7b2b40a56eb9c7203ca50133b2da4fd8fdd4a5cf | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.24e-06 | 194 | 194 | 8 | f95c8dc242c9aebcadfe61b1ed033349cb7e5a88 | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_airway-epi_proximal_progenitor2_(4)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.33e-06 | 195 | 194 | 8 | d673f8844896d5c7b76a7bc7f6b88a039f1bc263 | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.51e-06 | 197 | 194 | 8 | b94645d57efe8d9e032bffb8c89af1f425c6421e | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_airway|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.61e-06 | 198 | 194 | 8 | 9a12e5e47236433e512c668005fe3f8be6fde95c | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 2.71e-06 | 199 | 194 | 8 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | Transverse-T_cell-Tfh|Transverse / Region, Cell class and subclass | 2.71e-06 | 199 | 194 | 8 | cbef8f95edf2e86e16c448a76068d7ed8f6b7748 | |
| ToppCell | Transverse-(1)_T_cell-(16)_Tfh|Transverse / shred on region, Cell_type, and subtype | 2.71e-06 | 199 | 194 | 8 | aa31e26d48066f865ca33251a33a28934c0a7a44 | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.71e-06 | 199 | 194 | 8 | a270630626df614f8605abddb7dee7c4d74f6149 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_ciliated-epi_ciliated_(14)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 8.13e-06 | 165 | 194 | 7 | 0c714e852f912b5749de4cb0895406673979b2e6 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_ciliated|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 8.13e-06 | 165 | 194 | 7 | 82530f96aaefe28a13bad0474bbad043f127a86c | |
| ToppCell | COVID-19-Heart-CM_+_Macrophage|COVID-19 / Disease (COVID-19 only), tissue and cell type | 9.88e-06 | 170 | 194 | 7 | 3f15242a1d3e4e9871d9170b2ef05842fb609c29 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.15e-05 | 174 | 194 | 7 | 84da9faff088d05233183b425385beb054c92d1b | |
| ToppCell | PND07-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.15e-05 | 174 | 194 | 7 | 6c36d607c48267a75ab4da6fb2fe3f931d1b3b52 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.19e-05 | 175 | 194 | 7 | d52794426f2703a80e91ae0a8ff2d8e0ce4aa4a8 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.19e-05 | 175 | 194 | 7 | 454f03e6109d65f5db08dbb41ecc19ffb6bbc4e0 | |
| ToppCell | droplet-Mammary_Gland-nan-21m-Endothelial-basal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.24e-05 | 176 | 194 | 7 | 27e5115fae5f0f63b333bc99fbf6a6d4c9182c46 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.24e-05 | 176 | 194 | 7 | 327a3e81b724252e36d786de92a3ffd721ea6d7b | |
| ToppCell | Control-Epithelial_alveolar-AT_1-Differentiating_AT1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.28e-05 | 177 | 194 | 7 | 9af14a056eb6d88c6f11b09f6d4c0d3448d647d5 | |
| ToppCell | facs-Kidney-nan-18m-Lymphocytic-B_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.38e-05 | 179 | 194 | 7 | f4fd214a9865c635d8a744ce5e0eff45174d3de4 | |
| ToppCell | facs-Kidney-nan-18m-Lymphocytic-B_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.38e-05 | 179 | 194 | 7 | 57d8d44a793314eec8f77030f4177bfe21d41652 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.54e-05 | 182 | 194 | 7 | ef65b095f4240d61cfd4a59aec19d72d324dba1d | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.54e-05 | 182 | 194 | 7 | 97a805783a1f2b055c21307db250e3688674eff3 | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.59e-05 | 183 | 194 | 7 | c5b10571599dc26476170b54b53f09c23e6b3117 | |
| ToppCell | COVID-19-Heart-CM_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.65e-05 | 184 | 194 | 7 | e737f0f14c49b07bbb04a165083ac32210bc5690 | |
| ToppCell | COVID-19-Heart-CM_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.71e-05 | 185 | 194 | 7 | 549eeb521c3985bff396ea0f202db21822efa51f | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.71e-05 | 185 | 194 | 7 | 98b8ee42b89d97e4c9db01740e0c193503c68f2c | |
| ToppCell | CV-Moderate-7|Moderate / Virus stimulation, Condition and Cluster | 1.71e-05 | 185 | 194 | 7 | a6c9203ce6c2892a4a369c9bcfb85720f01cbb3f | |
| ToppCell | Control-T_cells-Cycling_NK/T_cells|Control / group, cell type (main and fine annotations) | 1.71e-05 | 185 | 194 | 7 | 9766216b41ee62bbac4caa25cb98ec5627a24075 | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 1.71e-05 | 185 | 194 | 7 | 6baccb26f999145e51b91d94315bf8d4655bef31 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.71e-05 | 185 | 194 | 7 | 51dfe6ac7df8b330343b37e3bee71e5c65267189 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.71e-05 | 185 | 194 | 7 | a8c02cec3c414f3a0da9f2d6d28ce563b0030705 | |
| ToppCell | CV-Moderate-7|CV / Virus stimulation, Condition and Cluster | 1.77e-05 | 186 | 194 | 7 | 8571956890fc9894d766ba294a28e376b4aba428 | |
| ToppCell | pdx|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.77e-05 | 186 | 194 | 7 | de8e538c8767d41b8a52f5e58ba1affd4e7244c4 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.77e-05 | 186 | 194 | 7 | 888e85a025bd982d36c910db0f5a3385b1ca3b28 | |
| ToppCell | pdx-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.77e-05 | 186 | 194 | 7 | 0b88a87158a9ca8de3bf40a4ff1687150707a5f0 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.83e-05 | 187 | 194 | 7 | 73931a5ea73799095daff100b5f18853c57c74dc | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.89e-05 | 188 | 194 | 7 | beb2df2332a46cc81b10e8e29fc9829020111f03 | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 1.96e-05 | 189 | 194 | 7 | 0a82931b5f6c0a6427ca3edd5e2235ac49099d40 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.96e-05 | 189 | 194 | 7 | 7fbe855bfdb47d35e040b04a80fe4b729a3764e8 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.96e-05 | 189 | 194 | 7 | 06b35abecd29f902cf251fcc1f6ad33db7ab08a2 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway-epi_intermediate_(1)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.03e-05 | 190 | 194 | 7 | c95032bb3ee2b3d40fdf48016acb46d6f78a48a6 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.03e-05 | 190 | 194 | 7 | 70c86dd454afb21d4a85db56c5f369d4b342bc97 | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_airway-epi_intermediate_(1)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.10e-05 | 191 | 194 | 7 | 72dbd2e0fabfca8d6f604df35277d3574739a0b3 | |
| ToppCell | COVID-19-kidney-vSMC/Pericyte|kidney / Disease (COVID-19 only), tissue and cell type | 2.10e-05 | 191 | 194 | 7 | fad8eaa536001b911d05ae2b12150c2398cc6f88 | |
| ToppCell | MS-Treg-exh_CD4|MS / Condition, Cell_class and T cell subcluster | 2.17e-05 | 192 | 194 | 7 | c6722bf142c84ccedd99c1a3344085aecb4cbab4 | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_airway-epi_intermediate_(1)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.17e-05 | 192 | 194 | 7 | b73f24d1c55dfef1eb01c26da117dbf637ea080a | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_airway-epi_proximal_progenitor2_(4)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.17e-05 | 192 | 194 | 7 | 450baeb5c3df7a9445472530002ce38f177a333c | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_airway|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.24e-05 | 193 | 194 | 7 | af6ec2c2ba92aef3e41531c3c7215b3300437bd9 | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_airway-epi_proximal_secretory_(0)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.24e-05 | 193 | 194 | 7 | b25cdca3a1e381784ae48ca73c51cbb6ac62b811 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.32e-05 | 194 | 194 | 7 | f9070035553bc68106a9e0bdf4b507715a138aba | |
| ToppCell | PCW_05-06-Epithelial|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.32e-05 | 194 | 194 | 7 | 47a1369c22fcbfe00b08376eb610a61c355548db | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_airway-epi_proximal_secretory_(0)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.32e-05 | 194 | 194 | 7 | b19e16a76d7342ff9a665d19c9151652916f17d4 | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_airway-epi_intermediate_(1)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.40e-05 | 195 | 194 | 7 | d67a2b489c29bfd575751c13d2a5b1efdec5240a | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.48e-05 | 196 | 194 | 7 | b8759e6231e0254797d6c30930407b79440c57bb | |
| ToppCell | PCW_10-12-Epithelial|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.48e-05 | 196 | 194 | 7 | 9bfb31ff3e4f2c0a9405c418c86bfec5dbca23e2 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.56e-05 | 197 | 194 | 7 | 3d13a4f2e86422900ee2194e8a1fd1cf9750d5d3 | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.64e-05 | 198 | 194 | 7 | b598ab958e31f1e98bd06dc0097b58ac3a3f90a3 | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_1|Control_saline / Treatment groups by lineage, cell group, cell type | 2.64e-05 | 198 | 194 | 7 | 9b161285df7a4e51618f3517cfc5b8221ba55786 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.82e-05 | 200 | 194 | 7 | 8683445ad5b70748c4a1f12eb77d47623085147e | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_only / Treatment groups by lineage, cell group, cell type | 2.82e-05 | 200 | 194 | 7 | 2dadf317a42a7e27cc1fac74f91b806c93a57108 | |
| ToppCell | Bronchial-NucSeq-Stromal-Myofibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.82e-05 | 200 | 194 | 7 | a66449b22b39dd6987fc2c3ed160d24564234ced | |
| ToppCell | severe_COVID-19-cDC|severe_COVID-19 / disease group, cell group and cell class (v2) | 6.55e-05 | 157 | 194 | 6 | ec1978e07e2214048d015d8bb793c1d9991f6e37 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.53e-05 | 161 | 194 | 6 | 5fba13f0aa5002f7eefe219e2c6a07e163f1a50d | |
| ToppCell | E16.5-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.79e-05 | 162 | 194 | 6 | 34b4cd3d2258f88dfbd6d32abd1db87aff8a6b6f | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Macrophage-macrophage,_alveolar-Macro_c2-CCL3L1|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.06e-05 | 163 | 194 | 6 | 130c84bca3f72ab7d1a4fee2990c3d01600318ed | |
| ToppCell | ICU-SEP-Lymphocyte-T_NK-MAIT|ICU-SEP / Disease, Lineage and Cell Type | 8.33e-05 | 164 | 194 | 6 | db863a44fc0dad5518c47fdbf64ea21d6f36f089 | |
| ToppCell | E16.5-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2-AT1/AT2_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.33e-05 | 164 | 194 | 6 | fe11fcce4ba7f44ba2989ea3705916b67e75f8e7 | |
| ToppCell | E16.5-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.33e-05 | 164 | 194 | 6 | b6beb8548ac0dd07e8a580a938e5ee4bf25a3c1f | |
| ToppCell | droplet-Liver-LIVER-NPC-1m-Lymphocytic-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.62e-05 | 165 | 194 | 6 | 8c7a6f9e2ca0ce077426d3d0726e3f5a4c03b296 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Macrophage_Dendritic-Classical_Dendritic_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 8.91e-05 | 166 | 194 | 6 | 63dc58864268b4e7779e4c45155022556fc634f9 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(non-nasal)-Club_(non-nasal)_L.0.4.0.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.91e-05 | 166 | 194 | 6 | 9e98e6070055bfc780becee52d77830e06b6d854 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.21e-05 | 167 | 194 | 6 | 83969c36ac44b96afc9aa09400a99fa2b487f7ff | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.21e-05 | 167 | 194 | 6 | b4ef07117d14da3d5fbced949e4dfcb01c392295 | |
| ToppCell | facs-Lung-EPCAM-24m-Endothelial-Lymphatic_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.21e-05 | 167 | 194 | 6 | 961e722442d786ab15d1e490941d2be265a9057a | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.21e-05 | 167 | 194 | 6 | 94fc7df7ca55cd722a8dbd153201a29891217473 | |
| ToppCell | facs-Lung-EPCAM-24m-Endothelial-endothelial_cell_of_lymphatic_vessel|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.21e-05 | 167 | 194 | 6 | 3760efc35d4e7e9c2da1a20f9795ddea397e2206 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.21e-05 | 167 | 194 | 6 | eff3723fe60755272eca237459165e436e919ece | |
| ToppCell | RV-03._Atrial_Cardiomyocyte|RV / Chamber and Cluster_Paper | 9.64e-05 | 105 | 194 | 5 | 49e16b11f16e83a7d17d162c14bce991201bcc2a | |
| ToppCell | facs-Marrow-T-cells-3m-Hematologic-MPP_Fraction_B_+_C|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.02e-04 | 170 | 194 | 6 | d70aaa0f4e5034bb9f61b832b5f9123870936d3c | |
| ToppCell | PBMC-Convalescent-Lymphocyte-B-B_cell-B_naive-B_naive-5|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.05e-04 | 171 | 194 | 6 | 23b3120706bb9c20b9214fe3760c6d7a84f1e749 | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-Pecam____kidney_capillary_endothelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.08e-04 | 172 | 194 | 6 | 073a503dc922e3e3ac3528e249b0f8b74402110b | |
| ToppCell | tumor_Lymph_Node_/_Brain-T/NK_cells-CD8+/CD4+_Mixed_Th|T/NK_cells / Location, Cell class and cell subclass | 1.12e-04 | 173 | 194 | 6 | 42c911ed16fabdabef063830e8407192d8bde950 | |
| ToppCell | FLU-Healthy-3|Healthy / Virus stimulation, Condition and Cluster | 1.12e-04 | 173 | 194 | 6 | 26e89ac86922f1cd0100cf4d1cce37e74dd31c88 | |
| Drug | AC1L32OA | 5.98e-07 | 9 | 192 | 4 | CID000107745 | |
| Drug | Evoxine [522-11-2]; Down 200; 11.6uM; PC3; HT_HG-U133A | EPOR INPP4A UTRN BAHCC1 KRAS REXO5 SMG5 PPM1G ELMO3 ALOXE3 MX1 | 1.01e-06 | 198 | 192 | 11 | 3681_DN |
| Drug | L 744832 | 2.35e-06 | 4 | 192 | 3 | ctd:C096898 | |
| Disease | RASopathy (implicated_via_orthology) | 1.68e-07 | 9 | 181 | 4 | DOID:0080690 (implicated_via_orthology) | |
| Disease | Verrucous epidermal nevus | 2.27e-07 | 3 | 181 | 3 | C0362030 | |
| Disease | Nevus Sebaceus of Jadassohn | 2.27e-07 | 3 | 181 | 3 | C4552097 | |
| Disease | Organoid Nevus Phakomatosis | 2.27e-07 | 3 | 181 | 3 | C0265329 | |
| Disease | Linear nevus sebaceous syndrome | 2.27e-07 | 3 | 181 | 3 | cv:C4552097 | |
| Disease | Nevus sebaceous | 2.27e-07 | 3 | 181 | 3 | C3854181 | |
| Disease | Inflammatory linear verrucous epidermal nevus | 2.27e-07 | 3 | 181 | 3 | C0473574 | |
| Disease | SCHIMMELPENNING-FEUERSTEIN-MIMS SYNDROME | 2.27e-07 | 3 | 181 | 3 | 163200 | |
| Disease | linear nevus sebaceous syndrome (is_implicated_in) | 2.27e-07 | 3 | 181 | 3 | DOID:0111530 (is_implicated_in) | |
| Disease | Noonan syndrome 3 (implicated_via_orthology) | 2.27e-07 | 3 | 181 | 3 | DOID:0060581 (implicated_via_orthology) | |
| Disease | Linear Verrucous Epidermal Nevus | 2.27e-07 | 3 | 181 | 3 | C3179502 | |
| Disease | cervical cancer (implicated_via_orthology) | 2.27e-07 | 3 | 181 | 3 | DOID:4362 (implicated_via_orthology) | |
| Disease | Noonan Syndrome 1 | 4.37e-07 | 11 | 181 | 4 | C4551602 | |
| Disease | Turner Syndrome, Male | 4.37e-07 | 11 | 181 | 4 | C0041409 | |
| Disease | Female Pseudo-Turner Syndrome | 4.37e-07 | 11 | 181 | 4 | C1527404 | |
| Disease | kidney cancer (implicated_via_orthology) | 4.37e-07 | 11 | 181 | 4 | DOID:263 (implicated_via_orthology) | |
| Disease | hair colour measurement | HDAC9 HDAC4 NR6A1 ATG2A CLIC5 PKHD1 HERC2 KRAS NRAS MYH7B APBA2 REV3L SHOC2 PPM1G VPS9D1 PARD3 | 1.40e-06 | 615 | 181 | 16 | EFO_0007822 |
| Disease | RASopathy | 1.77e-06 | 15 | 181 | 4 | cv:C5555857 | |
| Disease | NEVUS, EPIDERMAL (disorder) | 2.25e-06 | 5 | 181 | 3 | C0334082 | |
| Disease | Follicular thyroid carcinoma | 2.25e-06 | 5 | 181 | 3 | C0206682 | |
| Disease | Hemimegalencephaly | 4.48e-06 | 6 | 181 | 3 | C0431391 | |
| Disease | Noonan-Like Syndrome With Loose Anagen Hair | 4.94e-06 | 19 | 181 | 4 | C3501846 | |
| Disease | Noonan syndrome-like disorder with loose anagen hair | 4.94e-06 | 19 | 181 | 4 | C1843181 | |
| Disease | Cardio-facio-cutaneous syndrome | 4.94e-06 | 19 | 181 | 4 | C1275081 | |
| Disease | Costello syndrome (disorder) | 4.94e-06 | 19 | 181 | 4 | C0587248 | |
| Disease | Colorectal Carcinoma | ACACA OBSCN CLSTN2 FANCG FBLN2 FBN2 SACS PKHD1 DMD UHRF2 KRAS NRAS TGM2 NEURL1 LONRF2 FBXW7 | 7.53e-06 | 702 | 181 | 16 | C0009402 |
| Disease | LEOPARD Syndrome | 9.19e-06 | 22 | 181 | 4 | C0175704 | |
| Disease | Leukemia, Myelocytic, Acute | 1.23e-05 | 173 | 181 | 8 | C0023467 | |
| Disease | Noonan Syndrome | 1.32e-05 | 24 | 181 | 4 | C0028326 | |
| Disease | leukemia | 2.23e-05 | 55 | 181 | 5 | C0023418 | |
| Disease | Adenocarcinoma of large intestine | 2.88e-05 | 96 | 181 | 6 | C1319315 | |
| Disease | hypertrophic cardiomyopathy (implicated_via_orthology) | 2.89e-05 | 29 | 181 | 4 | DOID:11984 (implicated_via_orthology) | |
| Disease | RAS-ASSOCIATED AUTOIMMUNE LEUKOPROLIFERATIVE DISORDER | 3.74e-05 | 2 | 181 | 2 | 614470 | |
| Disease | Autoimmune lymphoproliferative syndrome type 4 | 3.74e-05 | 2 | 181 | 2 | cv:C2674723 | |
| Disease | autoimmune lymphoproliferative syndrome type 4 (is_implicated_in) | 3.74e-05 | 2 | 181 | 2 | DOID:0110117 (is_implicated_in) | |
| Disease | MELANOCYTIC NEVUS SYNDROME, CONGENITAL | 3.74e-05 | 2 | 181 | 2 | 137550 | |
| Disease | Melanocytic nevus | 3.74e-05 | 2 | 181 | 2 | cv:C0027962 | |
| Disease | RAS-ASSOCIATED AUTOIMMUNE LEUKOPROLIFERATIVE DISORDER | 3.74e-05 | 2 | 181 | 2 | C2674723 | |
| Disease | large congenital melanocytic nevus (is_implicated_in) | 3.74e-05 | 2 | 181 | 2 | DOID:0111359 (is_implicated_in) | |
| Disease | Large congenital melanocytic nevus | 3.74e-05 | 2 | 181 | 2 | cv:C1842036 | |
| Disease | carcinoma (implicated_via_orthology) | 4.67e-05 | 64 | 181 | 5 | DOID:305 (implicated_via_orthology) | |
| Disease | Thyroid Neoplasm | 7.72e-05 | 37 | 181 | 4 | C0040136 | |
| Disease | glucose homeostasis measurement, glucose effectiveness measurement | 9.78e-05 | 15 | 181 | 3 | EFO_0006833, EFO_0006896 | |
| Disease | Lymphoma | 1.05e-04 | 40 | 181 | 4 | C0024299 | |
| Disease | cholic acid glucuronide measurement | 1.12e-04 | 3 | 181 | 2 | EFO_0800574 | |
| Disease | GIANT PIGMENTED HAIRY NEVUS | 1.12e-04 | 3 | 181 | 2 | C1842036 | |
| Disease | hereditary spastic paraplegia (implicated_via_orthology) | 1.40e-04 | 43 | 181 | 4 | DOID:2476 (implicated_via_orthology) | |
| Disease | creatinine measurement | CAND1 INPP4A OBSCN DLGAP3 NFE2L2 PKHD1 DLEC1 UHRF2 DENND5B MYH7B ACAD10 PPM1G FRY FAM53B FBXL20 PARD3 PCK1 | 1.44e-04 | 995 | 181 | 17 | EFO_0004518 |
| Disease | non-alcoholic steatohepatitis (biomarker_via_orthology) | 1.45e-04 | 17 | 181 | 3 | DOID:0080547 (biomarker_via_orthology) | |
| Disease | autosomal dominant intellectual developmental disorder (is_implicated_in) | 1.45e-04 | 17 | 181 | 3 | DOID:0060307 (is_implicated_in) | |
| Disease | Malignant Head and Neck Neoplasm | 1.53e-04 | 44 | 181 | 4 | C0278996 | |
| Disease | high grade glioma (implicated_via_orthology) | 1.53e-04 | 44 | 181 | 4 | DOID:3070 (implicated_via_orthology) | |
| Disease | Thyroid carcinoma | 1.53e-04 | 44 | 181 | 4 | C0549473 | |
| Disease | Primary Ciliary Dyskinesia | 1.99e-04 | 47 | 181 | 4 | C4551720 | |
| Disease | leukemia (implicated_via_orthology) | 2.05e-04 | 19 | 181 | 3 | DOID:1240 (implicated_via_orthology) | |
| Disease | NEVUS, EPIDERMAL | 2.23e-04 | 4 | 181 | 2 | 162900 | |
| Disease | X-25937 measurement | 2.23e-04 | 4 | 181 | 2 | EFO_0800937 | |
| Disease | Malignant neoplasm of penis | 2.23e-04 | 4 | 181 | 2 | C0153601 | |
| Disease | Penile Neoplasms | 2.23e-04 | 4 | 181 | 2 | C0030849 | |
| Disease | Nevus, Keratinocytic, Nonepidermolytic | 2.23e-04 | 4 | 181 | 2 | C4011754 | |
| Disease | BLADDER CANCER | 2.23e-04 | 4 | 181 | 2 | 109800 | |
| Disease | Epidermal nevus | 2.23e-04 | 4 | 181 | 2 | cv:C0334082 | |
| Disease | Malignant tumor of urinary bladder | 2.23e-04 | 4 | 181 | 2 | cv:C0005684 | |
| Disease | Thyroid cancer, nonmedullary, 2 | 2.23e-04 | 4 | 181 | 2 | cv:C4225426 | |
| Disease | Malignant tumor of cervix | 2.23e-04 | 4 | 181 | 2 | C0007847 | |
| Disease | epidermal nevus (is_implicated_in) | 2.23e-04 | 4 | 181 | 2 | DOID:0111162 (is_implicated_in) | |
| Disease | THYROID CANCER, NONMEDULLARY, 2 | 2.23e-04 | 4 | 181 | 2 | 188470 | |
| Disease | Malignant neoplasm of liver | 2.52e-04 | 142 | 181 | 6 | C0345904 | |
| Disease | Liver neoplasms | 2.52e-04 | 142 | 181 | 6 | C0023903 | |
| Disease | Sarcoma | 2.78e-04 | 21 | 181 | 3 | C1261473 | |
| Disease | Splenomegaly | 3.21e-04 | 22 | 181 | 3 | C0038002 | |
| Disease | Antithrombotic agent use measurement | 3.66e-04 | 55 | 181 | 4 | EFO_0009925 | |
| Disease | THYROID CANCER, NONMEDULLARY, 2 | 3.70e-04 | 5 | 181 | 2 | C4225426 | |
| Disease | Malignant neoplasm of thyroid | 3.70e-04 | 5 | 181 | 2 | C0007115 | |
| Disease | Cetuximab response | 3.70e-04 | 5 | 181 | 2 | cv:CN077967 | |
| Disease | Cervix carcinoma | 3.70e-04 | 5 | 181 | 2 | C0302592 | |
| Disease | Panitumumab response | 3.70e-04 | 5 | 181 | 2 | cv:CN077999 | |
| Disease | Intellectual Disability | 4.67e-04 | 447 | 181 | 10 | C3714756 | |
| Disease | Fanconi Anemia | 4.73e-04 | 25 | 181 | 3 | C0015625 | |
| Disease | Acute monocytic leukemia | 5.32e-04 | 26 | 181 | 3 | C0023465 | |
| Disease | Pleocytosis | 5.52e-04 | 6 | 181 | 2 | C0151857 | |
| Disease | Autoimmune lymphoproliferative syndrome | 5.52e-04 | 6 | 181 | 2 | cv:CN301239 | |
| Disease | Carcinoma in situ of uterine cervix | 5.52e-04 | 6 | 181 | 2 | C0851140 | |
| Disease | seminoma (is_implicated_in) | 5.52e-04 | 6 | 181 | 2 | DOID:4440 (is_implicated_in) | |
| Disease | Leukocytosis | 5.52e-04 | 6 | 181 | 2 | C0023518 | |
| Disease | stimulant use measurement | 6.64e-04 | 28 | 181 | 3 | EFO_0600076 | |
| Disease | lumbar disc degeneration | 6.64e-04 | 28 | 181 | 3 | EFO_0004994 | |
| Disease | Miller Dieker syndrome | 7.38e-04 | 29 | 181 | 3 | C0265219 | |
| Disease | Thyroid cancer, follicular | 7.70e-04 | 7 | 181 | 2 | C2931367 | |
| Disease | X-24574 measurement | 7.70e-04 | 7 | 181 | 2 | EFO_0800897 | |
| Disease | Acute lymphocytic leukemia | 7.70e-04 | 7 | 181 | 2 | C0023449 | |
| Disease | Thymic Carcinoma | 7.70e-04 | 7 | 181 | 2 | C0205969 | |
| Disease | MYELODYSPLASTIC SYNDROME | 7.77e-04 | 67 | 181 | 4 | C3463824 | |
| Disease | colorectal cancer (implicated_via_orthology) | 8.16e-04 | 30 | 181 | 3 | DOID:9256 (implicated_via_orthology) | |
| Disease | cardiomyopathy (implicated_via_orthology) | 9.66e-04 | 71 | 181 | 4 | DOID:0050700 (implicated_via_orthology) | |
| Disease | intestinal cancer (implicated_via_orthology) | 9.88e-04 | 32 | 181 | 3 | DOID:10155 (implicated_via_orthology) | |
| Disease | Alzheimer's disease biomarker measurement, brain volume measurement | 1.02e-03 | 8 | 181 | 2 | EFO_0006514, EFO_0006930 | |
| Disease | deoxycholic acid glucuronide measurement | 1.02e-03 | 8 | 181 | 2 | EFO_0800575 | |
| Disease | NEURAL TUBE DEFECTS, SUSCEPTIBILITY TO | 1.02e-03 | 8 | 181 | 2 | C3891448 | |
| Disease | Squamous cell carcinoma | 1.03e-03 | 124 | 181 | 5 | C0007137 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PDLQSRGELCELLET | 356 | Q13075 | |
| PDEGLASIICDQLLE | 511 | Q13075 | |
| EEGISTCENLQDLLL | 246 | Q96RT1 | |
| LVDIGETLQCPEDLT | 86 | Q8TE69 | |
| LVDIGETLQCPEDLT | 86 | Q96DE9 | |
| PLEGLQELQCAALLE | 1181 | Q9P281 | |
| PGEVLIDCLDSIEDT | 26 | Q8N3I7 | |
| ACLEAEEAGLPLQVI | 206 | P19419 | |
| LLALDAVDPQGEEKC | 406 | Q9UL15 | |
| DAPLCEDVELQDGDL | 21 | Q9BWW8 | |
| AVCQLSEALLELGED | 616 | P33076 | |
| DCLLSLLQAGAEPDI | 186 | Q96Q27 | |
| LDGLEELELCPAGDL | 21 | O00155 | |
| DLLLAGNCEEIEPLQ | 486 | O75843 | |
| QDDTGCLFLTELLLE | 686 | Q9Y6B7 | |
| CLFLTELLLEPGNSE | 691 | Q9Y6B7 | |
| NDCDLTQLGIPAAEE | 516 | Q6JQN1 | |
| DQLCGRDPTLTDELL | 1046 | Q13085 | |
| PEVVALLVDRGCQLD | 96 | Q6NSI1 | |
| PETSLDCLENTLGVE | 321 | Q6XZF7 | |
| EGILVECDTVPNLLA | 1521 | O60706 | |
| CEPEDLIDGIIFAAN | 361 | Q99767 | |
| GALGEADVIECLSLE | 136 | Q3SXY8 | |
| TLLPEDCLLGEQICE | 271 | Q8TDJ6 | |
| LLEVEQLLNAPDLCA | 2011 | P11532 | |
| LLEICNLTPDTLSGD | 371 | Q9UMQ6 | |
| EVLACEDLELNPFDG | 31 | Q7L7V1 | |
| LDGDELTLADCNLLP | 631 | Q96NY7 | |
| VIGGDLDPRQECLEL | 701 | Q9H4D0 | |
| EEGGDPAQLLEILCS | 906 | Q8IWY9 | |
| DGDELTLADCNLLPK | 336 | Q9NZA1 | |
| GEELELSVESPCELR | 756 | Q2TAZ0 | |
| EGCPKEDILVTLNDL | 436 | Q8WWK9 | |
| IDGETCLLDILDTAG | 46 | P01112 | |
| IDGETCLLDILDTAG | 46 | P01116 | |
| IDGETCLLDILDTAG | 46 | P01111 | |
| LETNAPESICILDLE | 471 | P49792 | |
| NADLPCEIEREILAL | 601 | P35558 | |
| ELTLDSGDCILNVLD | 81 | Q7Z444 | |
| AARVCELEELGELSP | 271 | Q96PE3 | |
| ECLDLSNGDTILEDL | 96 | Q5VVQ6 | |
| GLESCINLEELTLDG | 926 | Q6ZRR7 | |
| ALCQFPKLEELSLEG | 86 | Q9UFC0 | |
| LLDQDCRPDSDGLNL | 301 | Q96PE2 | |
| LSEIELPCSEDLNLE | 1441 | Q9H1A4 | |
| EFILLGLTDCPELQS | 11 | Q96RB7 | |
| IENFPSDLECLGNLE | 246 | A4D1F6 | |
| DEINLAAPEILECLS | 836 | Q9NU22 | |
| EACVSALLGNELDPL | 986 | P56524 | |
| LPAEEVDVLLQRCEG | 266 | Q92619 | |
| VLAGPCLEETGELLL | 116 | Q66K74 | |
| RQELDPCNAELTILG | 1976 | Q5T1H1 | |
| ADICPLDVEENLTAG | 1686 | Q6PRD1 | |
| LCENDDLATSLVLDP | 11 | Q86Y97 | |
| CDNPDIVLLLVLAGA | 136 | Q9Y6X6 | |
| LPEDLGENVLLGCER | 591 | Q5IJ48 | |
| IAEICEELQNGLTPL | 4486 | O95714 | |
| PLLGQDTCLQTELER | 306 | Q9BYJ1 | |
| VDSAICQLSEDGVLP | 321 | A6NEK1 | |
| CDDLIIRPLESQGIE | 51 | O43513 | |
| KGDLPDCEADQLLQI | 166 | Q9H3M9 | |
| NCIGDFLKTLEDPDL | 1006 | Q86VP6 | |
| SLCSLDGELDIEQIE | 406 | Q14153 | |
| LPIECSELDGDLNSL | 391 | Q9P2D6 | |
| LPNSLPGDDQDECLL | 596 | P98095 | |
| ALELRALELCAGPAE | 126 | Q8WY41 | |
| AGEQLKADLLLEPCS | 311 | Q7Z406 | |
| IDFGLDLQPCIDLIE | 556 | A7E2Y1 | |
| NAERSLLILGIPDDC | 16 | A0A0J9YXQ4 | |
| GPLEQELVDCLESTL | 131 | Q32NB8 | |
| ELLNGPIDVSDLSLC | 311 | Q16236 | |
| LGCEAVTLLLELNPD | 1151 | O94915 | |
| EAADVLCILQAELPS | 176 | Q9H0H0 | |
| LALCTDRDLQEIGIP | 416 | O94830 | |
| VELCGSEQEALDLVP | 1506 | Q9P265 | |
| VLLELGPSIEEDCQK | 101 | Q99836 | |
| DLIDREQGEDCLLLL | 901 | P50748 | |
| ALLRCDQALELAPDD | 216 | Q1L5Z9 | |
| ESLELLVEALNVPCS | 301 | O15287 | |
| VDLCLLEESVGSLEG | 1496 | Q9UKK3 | |
| LLEPLGLECTFIDDI | 621 | Q9Y2J8 | |
| SLQIPDDCLSLEAIV | 666 | Q8NBF2 | |
| LPALTTIDLQDLADC | 71 | D6RGH6 | |
| DCLIEGDDENLIPGT | 406 | Q13093 | |
| ILIEDPDGSCALILD | 6061 | Q5VST9 | |
| TIGDLSICLDGLQLE | 131 | Q96J02 | |
| EDCGIVDSQLSAILP | 356 | O95522 | |
| VLAELLELGCPEQSL | 101 | A1A4V9 | |
| SCVLPDELLVQILAE | 2206 | Q4G0P3 | |
| LSSDVICIDDGPIAE | 231 | P54132 | |
| EPLSSLALEEQCLAL | 131 | Q9BTV6 | |
| ELVVCANGLRPLDEE | 336 | Q9UKT7 | |
| ILEADCDILIPAASE | 371 | P00367 | |
| ILLGDDLSLEDPTAC | 1866 | Q9P0X4 | |
| PGLLLDVCTKDLADA | 621 | Q96RY5 | |
| ELESQAVDALDLPGC | 481 | O95886 | |
| GPEKLLALDELIDSC | 246 | Q969H0 | |
| LALDELIDSCEPTQV | 251 | Q969H0 | |
| EQTLLPDEFVSCLGI | 586 | Q5VWK5 | |
| GLEENTLIASLCDLL | 771 | Q6ZUT9 | |
| CLSTAPDLEAEQLLG | 76 | Q96BJ8 | |
| ICGLDTETGLEPDEL | 21 | Q6IQ26 | |
| TETGLEPDELSALCQ | 26 | Q6IQ26 | |
| DLPIEEVLIVDLCAD | 756 | Q68D51 | |
| ASEVINPLIEELGCD | 216 | Q8N6I1 | |
| LLTEAAPILEDGNCE | 11 | Q9NRY5 | |
| GPEELLCFTERLEDL | 46 | P19235 | |
| LDELALEIGAKPDFC | 436 | Q99518 | |
| CSLGELPNLKEEDIL | 926 | Q7Z4H7 | |
| EAALGAELCEETPVN | 386 | Q12840 | |
| ELDLRCLSQALEEPE | 831 | Q9ULL0 | |
| DVGQILLVDLCLDDL | 161 | Q8WYP5 | |
| LGCEVVVLLLELNPD | 1201 | Q5TBA9 | |
| LAELPCLEDLVFVGN | 136 | Q4LDG9 | |
| CLEDLVFVGNPLEEK | 141 | Q4LDG9 | |
| EACVNALLGNELEPL | 966 | Q9UKV0 | |
| IILEDIDECQELPGL | 1646 | P35556 | |
| GLNEVLAGLELEDEC | 496 | Q9NQC7 | |
| LGPSEECQLKLELTA | 1026 | Q9Y238 | |
| EALQVGACPDQDVLL | 1111 | Q9NZJ4 | |
| GPTEEELLKLLDQCD | 586 | Q9Y597 | |
| NGNLEEIDGLLDCPI | 746 | Q9BXW9 | |
| EIDGLLDCPIFLTDL | 751 | Q9BXW9 | |
| PLNGDVTEDTLAECI | 81 | Q8IWE2 | |
| GGILDLDDILCDVAD | 56 | Q8TEW0 | |
| CQDELAELDPGTISV | 36 | Q15406 | |
| LQELEELELTNCPGA | 446 | Q8N461 | |
| EGSEPILEERLCVLN | 1616 | P46939 | |
| ANEALLPTLICDIAG | 311 | Q9BX59 | |
| DECGITDDQLLALLP | 386 | P78395 | |
| ESGLALCPEVQDLLE | 701 | Q9UPR3 | |
| QGDLGLCVAELELLS | 186 | Q14C87 | |
| EGLDQALPCLTELIL | 81 | P09661 | |
| LVDLGLEPSEADCIA | 356 | Q2TB90 | |
| LCLLEQLEVLDLEGN | 156 | Q8IYG6 | |
| LETNAPESICILDLE | 471 | P0DJD1 | |
| LEVIELDNCPLITDA | 356 | Q96IG2 | |
| DVILEVLDARDPLGC | 136 | Q9NVN8 | |
| GAIDSCLEALELDPS | 291 | Q08752 | |
| PDGENLEQDLCTFLI | 466 | Q8NEB9 | |
| VEELLDQCLAPDTSG | 476 | O15355 | |
| SIQEDLAEEAPCLQG | 1176 | O15357 | |
| PAEIGELCNLITLDV | 231 | Q9UQ13 | |
| DLDVCILPNAENSGI | 3291 | P08F94 | |
| PETELLGDCDTLQVD | 921 | Q01974 | |
| GDCENLSELILTENL | 286 | Q14160 | |
| SLLTDRLCQEPGEEE | 346 | Q8NEM2 | |
| LDTGDDLDPDIINIL | 2001 | Q9UHV7 | |
| ENLELTCGNLLEEDL | 296 | O60811 | |
| LEEPAVCRGLEESLG | 86 | Q8WZ82 | |
| ACQSLEDGSVPEILI | 41 | Q58G82 | |
| LLILGIPEDCDDAEF | 21 | P0CW24 | |
| LEQALGEPCDLDAAL | 11 | P36956 | |
| GEPCDLDAALLTDIE | 16 | P36956 | |
| TDIKPENILLCVGDA | 211 | Q9UPE1 | |
| LAQGLCRPEVAESLE | 486 | Q9C0B6 | |
| TILGLDLQNCSLEDP | 71 | Q6UW56 | |
| LSCLVELLEDPNISA | 56 | Q8TCG1 | |
| PLDGSENCSVLALEL | 351 | Q8TCG1 | |
| EDGILDICLILLDVN | 186 | P21980 | |
| DLGPKELSCTELQEL | 21 | Q9ULP9 | |
| CVLNELAQLGLEPRD | 271 | Q5JU69 | |
| ALALNCDAPLDDKIG | 536 | Q96PU4 | |
| LLDGPEEVLQAEACS | 131 | Q9HC57 | |
| SGAPEQAECVELLLA | 246 | Q9UID3 | |
| QAECVELLLALGEPA | 251 | Q9UID3 | |
| ELLLALGEPAEELCE | 256 | Q9UID3 | |
| AELIAELEGRCQLPA | 226 | Q96F44 | |
| NECLAEFGIDSLPID | 366 | Q96BR9 | |
| ENPELVEGRDLLSCT | 201 | Q969K7 | |
| PHSCEELQDIDLELG | 146 | Q6ZVK1 | |
| LLALPCGRDQEDVVS | 3576 | Q96T58 | |
| RGVQLLDSELVLPDC | 211 | O76050 | |
| ILSSPDGELVDVACE | 1821 | O60673 | |
| ACLGSLQELESEPVI | 601 | Q9Y6Q2 | |
| LTLDCDTLVNELEGD | 581 | Q96IC2 | |
| CVNQGTILLDLAPED | 1101 | O95271 | |
| ESQLILATAEPLCLD | 196 | Q8NEM7 | |
| EELLEGQPVLLSCQA | 566 | P35916 | |
| ELLTPGNLERECLEE | 56 | O14669 | |
| DQAAILPGKLELCSD | 346 | Q12968 | |
| VQKTEDAGLELLACP | 296 | Q96DC7 | |
| EDLILIGNELDLACG | 111 | Q7Z2W9 | |
| LAGANPAVITCDELL | 4051 | P78527 | |
| GDLVCEVDLGDLSPE | 326 | Q8N4Q0 | |
| CDREDLVELALPQLA | 361 | A8K0R7 | |
| DSQIDAPLEVEGCLI | 6 | Q63HK3 | |
| QFSALGLDPCLLEDE | 416 | Q9H1V8 | |
| GLDPCLLEDELDKSV | 421 | Q9H1V8 | |
| CPESGEEAVILLEDL | 116 | O15535 | |
| GRDEDPVCLQLDDIL | 31 | Q9NX01 | |
| FDVILADALNPCGEL | 146 | P54855 | |
| ADALNPCGELLAELF | 151 | P54855 | |
| AAAQELGLLVLESCP | 511 | Q9Y2B5 | |
| LLLQRELIEGEANPC | 111 | O75123 | |
| SLLDEVALEGLDGLC | 6 | Q12789 | |
| ETGRLCEPEVLNSLE | 256 | Q6PJT7 | |
| DLSIPGLSEQCVLVD | 896 | Q9UBN4 | |
| ADAVNPCGELLAELL | 151 | O75795 | |
| LRELQQPLLEGTECE | 6 | Q6ZNR0 | |
| KACGEVDLPSELQDL | 466 | O75962 | |
| CDGDLLPVLQENSIS | 11 | Q0P140 | |
| DLLEEGKATVPCLAE | 311 | P20591 | |
| ASVLCISPEELQEAL | 641 | Q8WXR4 | |
| LLDEECLLPHGTDEN | 506 | Q9NQX4 | |
| ETETLPNLERGICEL | 1171 | P54296 |